UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 10-K
[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 29, 2001
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number: 0-21068
SIGHT RESOURCE CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 04-3181524
(State or other jurisdiction (I.R.S. Employer
of incorporation or organization) Identification No.)
6725 Miami Avenue, Cincinnati, OH 45243
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (513) 527-9700
Securities registered pursuant to Section 12(b) of the Act: None.
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $.01 par value per share
(Title of Class)
Preferred Share Purchase Rights
(Title of Class)
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes [X] No [_]
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405
of Regulation S-K is not contained herein, and will not be contained, to the
best of registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K. [_]
The aggregate market value of the registrant's voting stock held by
non-affiliates of the registrant (without admitting that any person whose shares
are not included in such calculation is an affiliate) on March 26, 2002, was
approximately $4,547,000 based on the last sale price as reported by OTC.
1
As of March 26, 2002, the registrant had 30,667,709 shares of common stock
outstanding, which does not include 30,600 shares held as treasury stock.
DOCUMENTS INCORPORATED BY REFERENCE
The following documents (or parts thereof) are incorporated by reference into
the following parts of this Form 10-K: Certain information required in Part III
of this Annual Report on Form 10-K is incorporated from the registrant's Proxy
Statement for the Annual Meeting of Stockholders to be held on May 30, 2002.
2
PART I
Item 1. Business
General
Sight Resource Corporation (the "Company") manufactures, distributes and
sells eyewear and related products and services. As of December 29, 2001, the
Company's operations consisted of 116 eye care centers, with one regional
optical laboratory and distribution center, making it one of the fifteen largest
providers in the United States' primary eye care industry based upon sales. The
Company's eye care centers operate primarily under the brand names Cambridge Eye
Doctors, E.B. Brown Opticians, Eyeglass Emporium, Vision Plaza, Vision World,
Shawnee Optical and Kent Optical. The Company also provides or, where necessary
to comply with applicable law, administers the business functions of
optometrists, ophthalmologists and professional corporations that provide vision
related professional services.
Current Operations
Eye Care Centers
The Company's 116 eye care centers are located in major shopping malls, strip
shopping centers, urban locations and free-standing buildings and generally are
clustered within discrete market areas so as to maximize the benefit of
advertising strategies and to minimize the cost of supervising operations. The
Company operates its eye care centers through its wholly owned subsidiaries:
Cambridge Eye Associates, Inc. ("Cambridge Eye"); Douglas Vision World, Inc.
("Vision World"); E.B. Brown Opticals, Inc. ("E.B. Brown"); Vision Plaza Corp.
("Vision Plaza"); Eyeglass Emporium, Inc. ("Eyeglass Emporium"); Shawnee
Optical, Inc. ("Shawnee"); and Kent Optical, Inc. ("Kent"). The Company's
centers in Massachusetts, Rhode Island, Ohio and Louisiana are leading providers
of prescription and non-prescription eye care products and services in those
markets. In addition, the Company's eye care centers in Indiana, New Hampshire,
Pennsylvania, Mississippi and Michigan are leading providers in their local
markets.
The eye care centers are substantially similar in appearance within each
region and are operated under certain uniform standards and operating
procedures. Each eye care center carries a selection of eyeglass frames, ranging
in price from value models to designer collections. Lens and frame selections
include a variety of materials and styles. The Company continually analyzes
sales of its frames to keep its eye care centers stocked with a wide selection
of the latest in eyewear fashion and a proper assortment of styles, colors and
sizes. In addition to prescription eyewear, each eye care center also carries
fashion sunglasses and eyewear accessories. E.B. Brown's eye care centers also
offer hearing aids and audiology goods and services which are provided by
audiologists who service many of E.B. Brown's centers on a rotating schedule.
Each eye care center in Massachusetts, New Hampshire, Rhode Island,
Indiana, Louisiana, Mississippi, Pennsylvania and Michigan is staffed by one or
more licensed optometrists, a manager and a number of trained eye care
technicians and/or licensed opticians. The Company intends to continue to add
optometrists to several of its eye care centers in Ohio and Pennsylvania.
3
Centralized Optical Laboratory and Distribution Center
To meet the volume needs of the eye care centers for certain prescription
eyeglass lenses and the delivery needs of each center's customers, the Company
operates an optical laboratory and distribution center located in Cleveland,
Ohio. The facility is currently leased through March 2004 with a 10 year renewal
option. The optical laboratory provides complete services to the Company's eye
care centers, including polishing, cutting and edging, tempering, tinting and
coating of ophthalmic lenses. The distribution center provides and maintains an
inventory of all accessories and supplies necessary to operate the primary eye
care centers, as well as "ready made" eye care products, including contact
lenses and related supplies. The inventory of eyeglass lenses, frames, contact
lenses, accessories and supplies is acquired through a number of sources,
domestic and foreign. The Company is not dependent on any one supplier.
Management believes that the centralized optical laboratory and distribution
center has the capacity to accommodate additional multi-site eye care centers.
Managed Primary Eye Care
The Company implemented its SightCare program to address the expanding
enrollment of patients in managed primary eye care programs and the resulting
customer flow to designated providers of these managed primary eye care
services. SightCare is responsible for developing programs for third party
payors, securing new contracts for providing managed primary eye care services,
and ensuring the consistency and quality of managed primary eye care products
and services delivered by the Company.
As of December 29, 2001, the Company provided managed primary eye care
benefits to more than 50 organizations in the markets served by its chains,
including private companies, unions and leading health maintenance
organizations. The Company believes that its buying power, central laboratory,
in-center optometrists, and broad outreach within its markets, enable it to
deliver consistent, quality eyewear and primary eye care at competitive prices,
thereby positioning the Company to achieve a leadership position in managed
primary eye care in its markets.
4
Management Agreements
Many states have laws which prohibit or restrict the practice of optometry
by non-licensed persons or entities. See "Government Regulation." In states
which allow the Company to employ optometrists and ophthalmologists, the Company
plans on providing professional services directly. In other cases, the Company
intends to enter into management agreements with optometrists, ophthalmologists
and/or professional corporations which are expected to provide the professional
eye care services. The Company's wholly owned subsidiaries, Cambridge Eye,
Vision World, Vision Plaza and E.B. Brown each entered into a management
agreement with Optometric Providers, Inc. ("Optometric Providers"), Optometric
Care, Inc. ("Optometric Care"), Dr. John Musselman, a Professional Corporation
("Musselman"), and Ohio Optometric Providers, Inc. ("Ohio Optometric Providers")
(collectively, the "PCs"), respectively. Accordingly, Cambridge Eye operates as
the management service organization ("MSO") for Optometric Providers, Vision
World operates as the MSO for Optometric Care, Vision Plaza operates as the MSO
for Musselman and E.B. Brown operates as the MSO for Ohio Optometric Providers.
Cambridge Eye, Vision World, Vision Plaza and E.B. Brown, as MSOs, have
exclusive decision making authority for the ongoing major operations of the PCs,
with the exception of the provision of professional eye care services.
Pursuant to these management agreements, the Company, among other things,
(i) acts as the exclusive financial manager, business manager and administrator
of all business and administrative functions and services associated with the
provision of the professional services, (ii) orders and purchases all
professional and office inventory and supplies and arranges for the availability
of the same, (iii) maintains files and records, (iv) provides or arranges for
the provision of technical and ancillary service and support personnel, (v)
establishes, operates and maintains bookkeeping, payroll, accounting, billing
and collection systems, (vi) renders advice concerning the marketing of
services, (vii) develops and administers benefit plans for the professionals and
(viii) renders such other business and financial management, consultation and
advice as may reasonably be needed from time to time by the practice in
connection with its provision of professional services. As a result, the Company
is involved in the daily on-site financial and administrative management of
these optometric practices. The Company's goals in providing such services are
to (i) improve the performance of these optometric practices in these
non-professional practice activities, (ii) allow the optometrists employed by or
associated with these practices to more fully dedicate their time and efforts
toward their professional practice activities, and (iii) afford the Company
expanded service capabilities, and, for itself and on behalf of the optometric
practices, capitalize on opportunities for contracting with third party payors
and their intermediaries, including managed care providers. The management fees
payable to the Company by the affiliated practices under the management
agreements vary based on the cost, nature and amount of services provided, and
may be adjustable or subject to renegotiation from time to time. Management fees
payable under existing and future contracts are subject to the requirements of
applicable laws, rules and regulations and negotiations with individual
professional practices.
Under the management agreements, the affiliated practices retain the
responsibility for, among other things, (i) hiring and compensating
professionals, (ii) ensuring that professionals have the required licenses,
credentials, approvals and other certifications needed to perform their duties
and (iii) complying with applicable federal and state laws, rules and
regulations. In addition, the affiliated practices exclusively control all
aspects of professional practice and the delivery of professional services.
5
Stock Restrictions and Pledge Agreements
The outstanding voting capital stock of each of the PCs is 100% owned by a
licensed optometrist (the "nominee shareholder") who has, in turn, executed a
Stock Restrictions and Pledge Agreement (a "Pledge Agreement") in favor of the
respective MSO. Set forth below is a chart identifying each PC, the nominee
shareholder for each PC and the total number of employees for each PC as of the
end of fiscal 2001:
Name of PC Nominee Shareholder No. of Employees
---------- ------------------- ----------------
Optometric Providers, Inc. .......................... Alerino Iacobbo, O.D. 30 persons
Optometric Care, Inc. ............................... Alerino Iacobbo, O.D. 10 persons
Dr. John Musselman, a Professional Corporation ...... John Musselman, O.D. 20 persons
Ohio Optometric Providers, Inc. ..................... John Cress, O.D. 9 persons
Through each Pledge Agreement, the nominee shareholder has pledged all of
the outstanding voting capital stock of his PC to the respective MSO. The
Company requires that a nominee shareholder execute a Pledge Agreement in order
to provide security for the prompt payment, performance and observance by the PC
of all of its obligations, debts and covenants under its management agreement
with the MSO. The Pledge Agreement also contains restrictions on the nominee
shareholder's ability to transfer the stock of the PC, in order to provide that
the shareholder will at all times be a person eligible to hold such stock
pursuant to the provisions of applicable law, the PC's Articles of Organization
and the PC's By-Laws. The Pledge Agreement may be terminated only upon the
written agreement of the parties thereto or upon the termination of the
management agreement and satisfaction in full of all of the PC's obligations
thereunder. A nominee shareholder may not unilaterally terminate a Pledge
Agreement.
In order to provide for the orderly continuation of the PC's business and
affairs, each Pledge Agreement also enumerates several events or circumstances
that require or permit the MSO to effect a change of the nominee shareholder.
Upon the occurrence of any of the following events (each of which is enumerated
in the Company's form of Pledge Agreement), an MSO may require the nominee
shareholder to sell and transfer the stock of the PC to another person eligible
to serve as a new nominee shareholder: (i) the death or disability of the
nominee shareholder; (ii) the nominee shareholder's disqualification to practice
optometry in the relevant jurisdiction or any other event or circumstance the
effect of which is to cause the nominee shareholder to cease being eligible to
serve as the shareholder of the PC; (iii) the transfer, by operation of law or
otherwise, of the nominee shareholder's shares of stock in the PC to a person
who is not eligible to serve as the shareholder of the PC; (iv) the termination
of the nominee shareholder's employment by the PC or by the Company (including
its subsidiaries); (v) the occurrence of any other event or the existence of any
other condition which, in the reasonable opinion of the MSO (in its capacity as
exclusive business manager and administrator of the professional corporation),
impairs or renders less-than-optimal the Company's business management and
administration of all of the business and administrative functions and services
of the PC; or (vi) the occurrence of any other event or the existence of any
other condition which might require or otherwise result in the sale or transfer
by the nominee shareholder (or his estate or personal representative) of the
6
nominee shareholder's shares of stock in the PC. The purchase price for a sale
of the PC's stock is equal to the aggregate book value of the PC. The Company
believes that such book value will always be a nominal cost because each PC
operates and expects to continue to operate at an almost break-even level
generating a nominal profit, if any at all, and each PC does not own or hold or
plan to own or hold any significant assets of any nature.
The Company believes that the events or circumstances identified in
clauses items (iv) and (v) are entirely within the Company's control. For
example, as there are no employment agreements between the Company and any
nominee shareholder, each nominee shareholder is an "at-will" employee of the
MSO, whose employment can be terminated at any time, with or without cause.
Either of these events are entirely within the Company's control and, therefore,
these provisions provide the Company with the ability at all times to cause a
change in the nominee shareholder for an unlimited number of times, at nominal
cost. These provisions meet the criteria described in footnote 1 to Emerging
Issues Task Force 97-2, so that (i) the Company can at all times establish or
effect a change in the nominee shareholder, (ii) the Company can cause a change
in the nominee shareholder an unlimited number of times, that is, changing the
nominee shareholder one or more times does not affect the Company's ability to
change the nominee shareholder again and again, (iii) the Company has the sole
discretion without cause to establish or change the nominee shareholder, (iv)
the Company can name any qualified optometrist as a new nominee shareholder
(that is, the Company's choice of an eligible nominee is not materially
limited), (v) the Company and the nominally owned entity incur no more than a
nominal cost to cause a change in the nominee shareholder and (vi) neither the
Company nor the nominally owned entity is subject to any significant adverse
impact upon a change in the nominee shareholder. The Company effected the change
of the nominee shareholder for Optometric Providers in August of 1998, without
an adverse impact on the Company or the PC. The Company does not believe that
any future change in any nominee shareholder would have a significant adverse
impact on it or any PC. To date, the Company's experience with the nominee
shareholders has been satisfactory.
Termination of Laser Vision Correction Services
The Company had a refractive laser access agreement with Laser Vision
Centers, Inc. ("LVCI") in order to provide refractive laser services to its
patients. The agreement called for LVCI to provide Company patients with
refractive laser services in conjunction with affiliated LVCI ophthalmologists
in the Company's selected markets. In March 2002, after the Company determined
that it would no longer provide refractive laser services, the Company and LVCI
mutually terminated the agreement effective February 28, 2002. During fiscal
2001, revenue and operating profit under this agreement were $275,000 and
$33,000, respectively.
Marketing and Merchandising
The Company's marketing and merchandising strategy focuses on the
following key concepts: (i) selling quality, brand name and private-label
eyewear at competitive prices; (ii) offering a wide selection of eyewear
products; (iii) offering convenient locations and hours, and in-house optometric
examinations by licensed optometrists; (iv) using a variety of media, such as
radio, newspaper, direct mail, television and yellow pages advertising, to
differentiate it from competitors and to create general consumer awareness and
traffic in its eye care centers; and (v) providing knowledgeable and
personalized customer service.
The Company makes use of various tools to market its products and services
including those listed below:
Advertising. The Company uses newspaper, television, radio, direct mail,
telemarketing and other advertising to reach prospective as well as existing
customers. Advertisements emphasize the Company's
7
benefits to the eyewear public, such as value pricing, product promotions,
convenience of location, customer service and knowledgeable salespersons.
In-house optometric examinations by licensed optometrists are also emphasized in
advertising, subject to regulatory requirements.
In-center Marketing. The Company prepares and revises point-of-purchase
displays which convey promotional messages to customers upon arriving at its
centers. The Company also employs visual merchandising techniques, interactive
displays, and take-home brochures to draw attention to products displayed in the
eye care centers.
Monthly Direct Mail. The Company delivers monthly direct mail to customers
who are in its customer database. This database consists of individuals who have
utilized the services of the Company and its affiliated professionals over the
last several years. The mail includes educational, promotional and marketing
information about the Company's products and services. The monthly direct mail
program is an effort to reach customers in a more frequent and timely manner
than the Company's previous practice of quarterly mailings.
The Company markets its comprehensive and competitively priced primary eye
care programs to leading HMOs, insurance companies and other third party payors
in the Company's regional markets. The Company's marketing strategy towards
these organizations stresses its regional coverage, its complete range of eye
care products and services and its commitment to quality and service. Through
its SightCare programs the Company has upgraded and simplified its frame
collection available to managed care organizations in order to allow it to
compete more effectively for managed care contracts. Eventually, the Company
intends to offer its SightCare programs in all of its markets.
Acquisition History and Strategy
Effective January 1, 1995, the Company acquired the assets of Cambridge
Eye, an optometric practice which, at December 29, 2001 operated 20 primary eye
care centers, principally in Massachusetts. The assets and liabilities of
Cambridge Eye were acquired from a Company by the same name (Cambridge Eye
Associates, Inc.) owned by Elliot S. Weinstock, O.D. as the sole stockholder.
Following the acquisition, Cambridge Eye entered into a management services
contract with Optometric Providers, a professional corporation established to
employ the optometrists previously employed by the acquired company.
Effective July 1, 1995, the Company acquired the assets of Vision World, a
company which, at December 29, 2001, operated seven primary eye care centers in
Rhode Island. The assets and liabilities of Vision World were acquired from a
company by the same name (Douglas Vision World, Inc.) owned by Kathleen
Haronian, Lynn Haronian and Shirley Santoro. Following the acquisition, Vision
World entered into a management services contract with Optometric Care, a
professional corporation established to employ the optometrists previously
affiliated with the acquired company.
Effective July 1, 1996, the Company acquired the assets and liabilities of
three companies, the E.B. Brown Optical Company, Brown Optical Laboratories,
Inc. and E.B. Brown Opticians, Inc., all owned by Gordon and Evelyn Safran and
consolidated the operations of the three acquired companies into E.B. Brown. At
December 29, 2001, E. B. Brown operated 34 eye care centers in Ohio and western
Pennsylvania. Independent optometrists are associated with most of E.B. Brown
eye care centers; therefore, the Company does not record revenue from the
provision of vision related medical services at these locations. Since 2000,
E.B. Brown has a management services contract with Ohio Optometric Providers, a
professional corporation established to employ optometrists. The Company records
revenue from the provision of vision related medical services by optometrists
employed by Ohio Optometric Providers.
Effective July 1, 1997, the Company acquired all of the outstanding shares
of stock of Vision Holdings, Ltd. (formerly known as Dr. Greenberg, An Optometry
Corporation d/b/a Vision Plaza), which continued its operations through Vision
Plaza. At December 29, 2001, Vision Plaza operated 14 primary eye care centers
and one specialty eyewear centers in Louisiana and Mississippi. Following the
acquisition, Vision Plaza entered into a management services contract with
Musselman, a professional corporation established to employ the optometrists
previously employed by the acquired company.
Effective April 1, 1998, the Company acquired all of the outstanding shares
of stock of Eye Glass Emporium, Inc., which continued its operations as Eyeglass
Emporium. At December 29, 2001 Eyeglass Emporium operated eight primary eye care
centers in northwest Indiana. Independent optometrists are associated with all
Eyeglass Emporium eye care centers, therefore, the Company does not record
revenue from the provision of vision related medical services at these
locations.
8
Effective January 1, 1999, the Company acquired all of the outstanding
shares of stock of Shawnee Optical, Inc. which continued its operations as
Shawnee. At December 29, 2001, Shawnee operated 10 primary eye care centers in
western Pennsylvania and central Ohio. Independent optometrists are associated
with all Shawnee eye care centers, therefore, the Company does not record
revenue from the provision of vision related medical services at these
locations.
Effective April 1, 1999, the Company acquired all of the outstanding
shares of Kent Optical, Inc. and its associated companies and consolidated the
operations of these companies into Kent. At December 29, 2001, Kent operated 22
eye care centers in Michigan. Kent leases optometrists from a subcontractor and
records revenue from the provision of vision related medical services by these
optometrists.
In July 2001, the Company merged with eyeshop.com, inc. ("Eyeshop"), an
early-stage optical development company established by E. Dean Butler in late
1999. Eyeshop focused on developing an Internet-based method of selling and
distributing eyewear to consumers utilizing advanced technology to provide
accurate fit and function to the purchaser over the Internet. Concurrently with
the merger, the Company entered into two Common Stock Purchase Agreements under
which the former stockholders of Eyeshop purchased additional shares of the
Company's Common Stock. It was anticipated that, following the merger, available
cash resources of the combined companies would be devoted to continuation and
improvement of the business of the Company, with a decision to be made at a
future date as to when the Eyeshop web site development activities should be
resumed. As of March 2002, no decision has been made to resume Eyeshop web site
development activities.
Currently, the Company is focused on executing the operational aspects of
its business plan. As such the Company does not anticipate any near term
acquisitions. However, the Company has a long-term acquisition strategy to
acquire and integrate the assets of multi-site eye care centers and the
practices of eye care professionals and to employ or enter into management
services contracts with these professionals. This strategy includes both
expanding existing regional markets and entering new regional markets. The
Company will also target acquisitions in strategic markets that will serve as
platforms from which the Company can consolidate a given service area by making
and integrating additional "in-market" acquisitions.
In assessing potential acquisition candidates, the Company evaluates
qualitative issues such as the reputation of the eye care professional in the
local and national marketplace, the training and education of the eye care
professional, licensure and experience, Medicare and Medicaid compliance,
billing practices and operating history. Prior to entering any market, the
Company considers such factors as the local level of eye care competition,
networking and consolidation activity, the regulatory environment,
customer-provider ratios and the economic condition of the local market. The
Company from time to time also considers acquisitions of, or affiliations with,
ambulatory surgical centers, specialty eye hospitals and other complementary
practices and services that are consistent with its objective of being a leading
integrated provider of eye care products and services in select, regional
markets.
Competition
The optical industry is highly competitive and includes chains of retail
optical stores, multi-site eye care centers, and a large number of individual
opticians, optometrists, and ophthalmologists who provide professional services
and/or dispense prescription eyewear. Optical retailers generally serve
individual, local or regional markets, and, as a result, competition is
fragmented and varies substantially among locations and geographic areas. The
Company believes that the principal competitive factors affecting retailers of
prescription eyewear are location and convenience, quality and consistency of
product and service, price, product warranties, and a broad selection of
merchandise. The Company belives that it competes favorably in each of these
respects.
Eye care practices affiliated with the Company will compete with other
local eye care practices as well as managed care organizations. The Company
believes that changes in governmental and private reimbursement policies and
other factors have resulted in increased competition for consumers of eye care
services. The Company believes that cost, accessibility and quality of services
are the principal factors that affect competition.
The Company and its affiliated practices compete with other providers for
managed primary eye care contracts. The Company believes that trends toward
managed primary eye care have resulted in increased competition for such
contracts.
Government Regulation
The Company and its operations are subject to extensive federal, state and
local laws, rules and regulations affecting the healthcare industry and the
delivery of healthcare, including laws and regulations prohibiting the practice
of medicine and optometry by persons not licensed to practice
9
medicine or optometry, prohibiting control over optometrists or physicians in
the practice of optometry by parties not licensed to practice optometry or
medicine, prohibiting the unlawful rebate or unlawful division of fees and
limiting the manner in which prospective patients may be solicited. The Company
attempts to structure all of its operations so as to comply with the relevant
state statutes and regulations. The Company believes that its operations and
planned activities do not violate any applicable medical practice, optometry
practice, fee-splitting or other laws identified above. Laws and regulations
relating to the practice of medicine, the practice of optometry, fee-splitting
or similar laws vary widely from state to state and seldom are interpreted by
courts or regulatory agencies in a manner that provides guidance with respect to
business operations such as those of the Company. There can be no assurance that
courts or governmental officials with the power to interpret or enforce these
laws and regulations will not assert that the Company or certain transactions in
which it is involved are in violation of such laws and regulations. In addition,
there can be no assurance that future interpretations of such laws and
regulations will not require structural and organizational modifications of the
Company's business.
Services that are reimbursed by third party payors may be subject to
provisions of the Social Security Act (sometimes referred to as the
"anti-kickback" statute) and similar state laws that impose criminal and civil
sanctions on persons who solicit, offer, receive, or pay any remuneration,
whether directly or indirectly, in return for inducing the referral of a patient
for treatment or the ordering or purchasing of items or services that are paid
for in whole or in part by Medicare, Medicaid or other specified federal or
state programs, or, in some states, private payors. The federal government has
promulgated regulations that create exceptions or "safe harbors" for certain
business transactions. Transactions that are structured in accordance with such
safe harbors will not be subject to prosecution under federal law. In order to
obtain safe harbor protection, the business arrangement must satisfy each of and
every requirement of the applicable safe harbor(s). Business relationships that
do not satisfy each element of a safe harbor do not necessarily violate the
anti-kickback statute but may be subject to greater scrutiny by enforcement
agencies. Many state anti-kickback statutes do not include safe harbors and some
state anti-kickback statutes apply to all third party payors. The Company is
concerned about federal and state anti-kickback statutes only to the extent that
it provides healthcare services that are reimbursed by federal, state and in
some states, private third party payors. The Company believes its business
relationships and operations are in material compliance with applicable laws.
Nevertheless, there can be no assurance that the Company will not be required to
change its practices or experience a material adverse effect as a result of a
challenge by federal or state enforcement authorities under the foregoing
statutes.
Significant prohibitions against physician referrals have been enacted by
Congress. These prohibitions, commonly known as "Stark II," amended prior
physician self-referral legislation known as "Stark I" by dramatically enlarging
the field of physician-owned or physician-interested entities to which the
referral prohibitions apply. Effective December 31, 1994, Stark II prohibits a
physician from referring Medicare or Medicaid patients to an entity providing
"designated health services" in which the physician has an ownership or
investment interest, or with which the physician has entered into a compensation
arrangement. The designated health services include prosthetic devices, which
under applicable regulations and interpretations include one pair of eyeglasses
or contact lenses furnished after cataract surgery and intra-ocular lenses
provided at ambulatory surgery centers. The penalties for violating Stark II
include a prohibition on payment by these government programs and civil
penalties of as much as $15,000 for each violative referral and $100,000 for
participation in a "circumvention scheme." The Company's current business is not
governed by Stark I or II. To the extent the Company or any affiliated practice
is deemed to be subject to the prohibitions contained in Stark II for services,
the Company believes its activities fall within the permissible activities
defined in Stark II, including, but not limited to, the provision of in-office
ancillary services.
10
Environmental Regulation
The Company's business activities are not significantly affected by
environmental regulations and no material expenditures are anticipated in order
for the Company to comply with environmental regulations. However, the Company
is subject to certain regulations promulgated under the Federal Environmental
Protection Act with respect to grinding, tinting, edging and disposing of
ophthalmic lenses and solutions.
Proprietary Property
The Company has no licenses, patents or registered copyrights. The Company
does have various registered trademarks in the U.S., including "Sight Resource",
"Cambridge Eye Doctors", "E.B. Brown Opticians", "Eyeglass Emporium",
"Kidspecs", "Shawnee Optical", "Kent Optical", "SightCare" and "Vision Plaza",
"eyeshop" and "eyeshop.com".
Employees
As of December 29, 2001, the Company had 750 employees. The Company
intends to hire additional personnel it believes will be required for
advancement of the Company's activities.
The success of the Company's future operations depends in large part on
the Company's ability to recruit and retain qualified personnel over time. There
can be no assurance, however, that the Company will be successful in retaining
or recruiting personnel.
Business Risks and Cautionary Statements
Statements in this Annual Report on Form 10-K under the captions
"Business" and "Management's Discussion and Analysis of Financial Condition and
Results of Operations," as well as oral statements that may be made by the
Company or by officers, directors or employees of the Company acting on the
Company's behalf, that are not historical fact constitute "forward-looking
statements" within the meaning of the Private Securities Litigation Reform Act
of 1995. Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that could cause the actual results of the
Company to be materially different from the historical results or from any
results expressed or implied by such forward-looking statements. Such factors
include, but are not limited to, the risk factors set forth below.
The Company does not intend to update any forward-looking statements to
reflect events or circumstances after the date of such statements or to reflect
the occurrence of anticipated or unanticipated events.
Risks Related to the Company's Business
The Company had an accumulated deficit of $31.6 million as of December 29,
2001, and may never achieve or maintain profitability.
The Company has experienced losses in each year of operation since
inception in November 1992. For the fiscal year ended December 29, 2001, the
Company incurred a net loss of $5.5 million bringing its accumulated deficit to
$31.6 million at December 29, 2001. The Company may never achieve profitability
and, if it achieves profitability, it may not be able to maintain profitability.
11
The Company's primary loan facilities expire at December 31, 2002 and the
Company may not be able to obtain financing or refinancing at terms acceptable
to the Company.
As of December 29, 2001, the Company owed Fleet Bank $2.5 million under a
revolving loan and $5.7 million under a term loan. Interest rates on the loans
during 2002 are at prime rate with a minimum of 8% and a maximum of 11% The
principal payments during 2002 on the term loan are $100,000 per month. Given
the Company's history, including substantial historical losses, the Company may
not be able to obtain financing or refinancing at terms acceptable to the
Company. The Company is making every effort to refinance these loans on terms
that are acceptable to the Company. The failure to obtain additional financing
would result in the declaration of a default with such loan facilities and could
materially and adversely affect the Company's business and financial condition.
Any additional equity financing, if available, may be dilutive to the Company's
stockholders and any debt financing, if available, may involve restrictions on
the Company's financing and operating activities.
The Company has previously breached certain loan covenants for which
waivers of such breaches have been granted, but the Company may not be able to
obtain waivers of any future breaches of loan covenants that may occur, which
could result in a default under existing or future loan agreements.
The Company has previously defaulted on a credit line agreement due to
non-compliance with negative covenants relating to minimum net worth, minimum
debt service coverage, maximum funded debt service coverage and minimum net
profit. The Company has obtained waivers from the bank for all breaches of loan
covenants to date, but future breaches may occur for which the Company may not
be able to obtain waivers. Any breach that is not waived may result in the bank
declaring the breach to be a default under the loan agreement, which would
require immediate repayment of all outstanding principal and accrued interest at
a time when the Company may not be able to repay the bank. Accordingly, the
declaration of a default under the loan agreement could materially and adversely
affect the Company's business and financial condition.
The Company is dependent upon certain key management personnel and may not
be able to attract and retain additional personnel.
The Company's future success is dependent in part on the Company's ability
to retain certain key personnel, particularly E. Dean Butler, the Company's
Chairman and Carene S. Kunkler, the Company's President and Chief Executive
Officer, and the Company's ability to recruit and retain qualified personnel
over time. The Company may not be able to retain its existing personnel or
attract additional qualified employees in the future.
The primary eye care market is highly competitive. The Company's current
and potential competitors include many larger companies with substantially
greater financial, operating, marketing and support resources.
The optical industry is highly competitive and includes chains of retail
optical stores, multi-site eye care centers, and a large number of individual
opticians, optometrists and ophthalmologists who provide professional services
and/or dispense prescription eyewear. Because retailers of prescription eyewear
generally service local markets, competition varies substantially from one
location or geographic area to another. The Company believes that the principal
competitive factors affecting retailers of prescription eyewear are location and
convenience, quality and consistency of product and service, price, product
12
warranties, and a broad selection of merchandise. In the Company's current
regional markets, the Company faces competition from national and regional
retail optical chains which, in many cases, have greater financial resources
than the Company.
The Company may not be able to acquire new managed primary eye care
contracts and existing contracts may not be expanded in any meaningful way.
As an increasing percentage of optometric and ophthalmologic patients are
coming under the control of managed care entities, the Company believes that its
success will, in part, be dependent upon the Company's ability to negotiate, on
behalf of existing and prospective affiliated practices, contracts with HMOs,
employer groups and other private third party payors pursuant to which services
will be provided on a risk-sharing or capitated basis by some or all affiliated
practices. The proliferation of contracts that pass much of the risk of
providing care from the payor to the provider in markets the Company serves may
result in greater predictability of revenues, but greater unpredictability of
expenses. The Company may not be able to negotiate, on behalf of the affiliated
practices, satisfactory arrangements on a risk-sharing or capitated basis. In
addition, to the extent that patients or enrollees covered by such contracts
require more frequent or extensive care than anticipated, operating margins may
be reduced or, in the worst case, the revenues derived from such contracts may
be insufficient to cover the costs of the services provided. As a result,
affiliated practices may incur additional costs, which would reduce or eliminate
anticipated earnings under such contracts. Any such reduction or elimination of
earnings would have a material adverse affect on the Company's business and
results of operations.
The Company may be exposed to significant risk from liability claims if the
Company is unable to obtain insurance at acceptable costs or is otherwise unable
to protect itself against potential product liability claims.
The provision of professional eye care services entails an inherent risk of
professional malpractice and other similar claims. The Company does not
influence or control the practice of medicine or optometry by professionals or
have responsibility for compliance with certain regulatory and other
requirements directly applicable to individual professionals and professional
groups. As a result of the relationship between the Company's affiliated
practices and itself, the Company may become subject to some professional
malpractice actions under various theories. Claims, suits or complaints relating
to professional services provided by affiliated practices may be asserted
against the Company in the future.
The Company may not be able to retain adequate liability insurance at
reasonable rates and the Company's insurance may not be adequate to cover claims
asserted against it, in which event its business and results of operations may
be materially adversely affected.
The Company's operations and success are dependent upon its ability to
enter into agreements with health care providers.
Certain states prohibit the Company from practicing medicine, employing
physicians to practice medicine on the Company's behalf or employing
optometrists to render optometric services on the Company's behalf. Accordingly,
the success of the Company's operations as a full-service eye care provider
depends upon its ability to enter into agreements with health care providers,
including institutions, independent physicians and optometrists, to render
surgical and other professional services at facilities owned or managed by the
Company. The Company may not be able to enter into agreements with other health
care providers on satisfactory terms or such agreements may not be profitable to
the Company.
13
The Company is subject to extensive federal, state and local regulation,
which could materially affect the Company's operations.
The health care industry is highly regulated by federal, state and local
law. The regulatory environment in which the Company operates may change
significantly in the future. The Company expects to modify agreements and
operations from time to time as the business and regulatory environment changes.
Although the Company believes that its operations comply with applicable law,
the Company may not be able to address changes in the regulatory environment
successfully.
The Company's common stock was delisted from the Nasdaq Stock Market,
which makes it more difficult for stockholders to sell shares of the Company's
common stock.
On September 11, 2000, the Nasdaq National Market ("Nasdaq") terminated the
Company's listing on Nasdaq and the Company's common stock began trading on the
Over-the-Counter Bulletin Board (the "OTC"). Stockholders are likely to find it
more difficult to trade the Company's common stock on the OTC than on Nasdaq. In
order for the Company's common stock to resume trading on Nasdaq, the Company
must satisfy all of Nasdaq's requirements for initial listing, apply for listing
and be accepted for listing by Nasdaq. The Company does not currently satisfy
Nasdaq's initial listing requirements and may never satisfy Nasdaq's listing
requirements or, if the Company does satisfy such requirements in the future,
the Company's securities may not be accepted for listing by Nasdaq. If the
Company's securities are not accepted for listing on Nasdaq or another stock
exchange, it will also likely be more difficult for the Company to raise equity
capital.
The application of the "penny stock rules" could adversely affect the
market price of the Company's common stock.
On March 26, 2002, the last sale price of the Company's common stock was
$0.40 per share. Because the trading price of the Company's common stock is less
than $5.00 per share and the Company's common stock no longer trades on Nasdaq,
the Company's common stock comes within the definition of a "penny stock". The
"penny stock rules" impose additional sales practice requirements on
broker-dealers who sell the Company's securities to persons other than
established customers and accredited investors (generally for individuals, those
persons whose net worth is in excess of $1,000,000 or whose annual income
exceeds $200,000 individually or $300,000 together with their spouse). For
transactions covered by these rules, broker-dealers must satisfy certain
additional administrative criteria in order to effectuate sales of the Company's
common stock. These additional burdens imposed on broker-dealers may restrict
the ability of broker-dealers to sell the Company's securities and may affect
your ability to resell the Company's common stock.
Corporate Liability and Insurance
The provision of professional eye care services entails an inherent risk
of professional malpractice and other similar claims. The Company does not
influence or control the practice of medicine or optometry by professionals or
have responsibility for compliance with certain regulatory and other
requirements directly applicable to individual professionals and professional
groups. As a result of the relationship between the Company and its affiliated
practices, the Company may become subject to some professional malpractice
actions under various theories. There can be no assurance that claims, suits or
complaints relating to professional services provided by affiliated practices
will not be asserted against the Company in the future.
14
The Company maintains insurance coverage that it believes will be adequate
both as to risks and amounts. The Company believes that such insurance will
extend to professional liability claims that may be asserted against employees
of the Company that work on site at affiliated practice locations. In addition,
pursuant to the management agreements, the affiliated practices are required to
maintain professional liability and comprehensive general liability insurance.
The availability and cost of such insurance has been affected by various
factors, many of which are beyond the control of the Company and its affiliated
practices.
There can be no assurance that the Company will be able to retain adequate
liability insurance at reasonable rates, or that the insurance will be adequate
to cover claims asserted against the Company, in which event the Company's
business may be materially adversely affected.
Item 2. Description of Properties
At December 29, 2001, the Company leased space for 116 of the Company's
operating eye care centers (which range in size from approximately 600 to 6,200
square feet), one closed center, and the Company's office headquarters under
operating leases, which expire as follows, exclusive of renewal options.
At December 29, 2001
Year Number of leases expiring
---- -------------------------
2002 ........................................ 16
2003 ........................................ 19
2004 ........................................ 27
2005 ........................................ 16
2006 ........................................ 15
2007 and thereafter ......................... 19
In addition, the Company is currently in lease negotiations or is an at
will tenant for six eye care centers.
The Company's corporate headquarters occupies approximately 7,500 square
feet of space leased in Cincinnati, Ohio pursuant to a lease which expires in
2004. The Company believes that its facilities are adequate for its present
needs and that suitable space will be available to the Company upon commercially
reasonable terms to accommodate future needs. The Company vacated its previous
corporate headquarters located in Holliston, Massachusetts in early 2002 and
will pay a lease termination fee of $135,000 during 2002.
Item 3. Legal Proceedings
15
From time to time the Company's subsidiaries may be defendants in certain
lawsuits alleging various claims incurred in the ordinary course of business.
These claims are generally covered by various insurance policies, subject to
certain deductible amounts and maximum policy limits. In the opinion of
management, the resolution of existing claims should not have a material adverse
effect, individually or in the aggregate, upon the Company's business or
financial condition. There can be no assurance that future claims against the
Company or any of its subsidiaries will not have a material adverse effect on
the Company, its operations or financial condition.
Item 4. Submission of Matters to a Vote of Security Holders
No matters were submitted to a vote of security holders during the quarter
ended December 29, 2001.
16
PART II
Item 5. Market for Registrant's Common Equity and Related Stockholder Matters
Market for Company's Common Equity
The Company's common stock traded on the Nasdaq National Market ("Nasdaq")
under the symbol "VISN" from August 25, 1994 until September 10, 2000, at which
time Nasdaq terminated the Company's listing on Nasdaq. On September 11, 2000,
the Company's common stock began trading on the Over-the-Counter Bulletin Board
("OTC") under the symbol "VISN". The following table sets forth the high and low
sales prices for the common stock as reported by Nasdaq for the period from
December 26, 1999 until September 10, 2000, and the high and low bid prices for
the common stock as reported on the OTC for the period from September 11, 2000
until December 29, 2001. Over-the-counter market quotations reflect inter-dealer
prices, without retail mark-up, mark-down or commission and may not necessarily
represent actual transactions.
Common Stock
------------
High Low
---- ---
2000:
First Quarter ............................................... $2.75 $1.00
Second Quarter .............................................. 1.50 0.69
Third Quarter (on Nasdaq through September 10, 2000) ........ 1.00 0.31
Third Quarter (on the OTC commencing September 11, 2000) .... 0.50 0.38
Fourth Quarter .............................................. 0.38 0.06
2001:
First Quarter ............................................... $0.48 $0.16
Second Quarter .............................................. 0.67 0.25
Third Quarter ............................................... 0.51 0.13
Fourth Quarter .............................................. 0.35 0.14
The Company has not paid dividends to its common stockholders since its
inception and does not plan to pay cash dividends in the foreseeable future. The
Company's bank agreement prohibits payment of cash dividends. The Company
currently intends to retain earnings, if any, to finance the growth of the
Company. As of March 20, 2002, there were 210 holders of record of the Company's
common stock and approximately 2,900 beneficial owners of the Company's common
stock.
17
Item 6. Selected Financial Data
Year ended December
-------------------
2001(1) 2000 1999(2)(3) 1998(4) 1997(5)(6)(7)
------- ---- --------- ------- ------------
(In thousands, except per share amounts)
Statement of Operations Data:
Net revenue ............................ $ 58,949 $ 64,219 $ 67,034 $ 54,971 $ 44,576
Net loss ............................... (5,487) (5,004) (2,854) (985) (2,004)
Net loss per common share .............. (0.34) (0.55) (0.30) (0.11) (0.46)
Weighted average number of common
shares outstanding ..................... 18,490 9,228 9,181 8,867 8,669
Balance Sheet Data:
Working capital (deficit) .............. ($ 7,061) ($ 6,276) $ 1,088 $ 3,176 $ 4,243
Total assets ........................... 33,944 35,139 40,754 32,145 34,507
Non-current liabilities ................ 945 476 6,989 348 101
Stockholders' equity ................... 10,373 12,299 17,349 18,959 19,446
1. On May 23, 2001, the Company entered into a common stock purchase agreement
by and among the Company, Eyeshop and certain investors associated with
Eyeshop (the "Stock Purchase Agreement"), pursuant to which the Company
agreed to sell, in two tranches, an aggregate of 5,000,000 shares of its
common stock at a price of $0.20 per share for an aggregate purchase price
of $1.0 million to persons associated with Eyeshop. The Company closed on
the sale of the first tranche of 1,250,000 shares for $250,000 on May 23,
2001 and on the second tranche of 3,750,000 shares for $750,000 on July 20,
2001. On July 20, 2001, pursuant to an Agreement and Plan of Merger (the
"Merger Agreement") dated as of May 23, 2001 by and among the Company,
Eyeshop Acquisition Corporation, a Delaware corporation and wholly owned
subsidiary of the Company ("EAC"), and Eyeshop, EAC merged with and into
Eyeshop (the "Merger") and Eyeshop became a wholly owned subsidiary of the
Company. Pursuant to the Merger Agreement, Eyeshop stockholders exchanged
their Eyeshop stock for an aggregate of 7,306,662 shares of the Company's
common stock. Pursuant to the Merger Agreement, former Eyeshop stockholders
are also entitled to receive additional shares of the Company's common
stock if and when the options, warrants and other rights to receive the
Company's common stock that were held by the Company's security holders as
of May 23, 2001 are exercised. On May 31, 2001, the Company entered into a
common stock purchase agreement by and among the Company and certain
investors associated with Eyeshop, to sell an aggregate of 6,569,500 shares
of its common stock at a price of $0.20 per share for an aggregate purchase
price of approximately $1.31 million. The Company closed on the sale of the
these shares on July 20, 2001.
2. Effective April 1, 1999, the Company acquired all of the outstanding shares
of stock of Kent Optical, Inc. and its associated companies. The purchase
price paid in connection with this acquisition was $5,209,000 in cash,
$1,000,000 in notes payable over three years and 160,000 shares of common
stock. With respect to the shares issued, the Company agreed to issue
additional consideration if the per share market price of the Company's
common stock did not exceed a specified threshold during an agreed upon
time frame. On February 7, 2002, the Company entered into a settlement
agreement with John C. Cress, Timothy D. Westra and Kent Acquisition Corp.
in which the Company agreed to issue 1,100,606 unregistered shares of the
Company's common stock as additional consideration in connection with such
contingent obligations incurred in the acquisition. Those shares were
issued on February 27, 2002. At December 29, 2001, Kent operated 22 eye
care centers in Michigan.
3. Effective January 1, 1999, the Company acquired all of the outstanding
shares of stock of Shawnee Optical, Inc. The purchase price paid in
connection with this acquisition was $1,750,000 in cash, $300,000 in notes
payable over three years and 70,000 shares of common stock. With respect to
the shares issued, the Company agreed to issue additional consideration if
the per share market price of the Company's common stock did not exceed a
specified threshold during an agreed upon time frame. On March 20, 2001,
the Company entered into a Settlement Agreement and Mutual Release with the
former Shawnee stockholders in which the Company agreed to issue 238,000
shares of its common stock as additional consideration in connection with
such contingent obligations incurred in the acquisition. At December 29,
2001, Shawnee operated 10 eye care centers in Pennsylvania and Ohio.
18
4. Effective April 1, 1998, the Company acquired all of the outstanding
shares of stock of Eye Glass Emporium, Inc. The purchase price paid in
connection with this acquisition was $2,309,000 in cash, $350,000 in notes
payable in twelve equal quarterly installments commencing June 30, 1998
and 87,940 shares of common stock. At December 29, 2001, Eyeglass Emporium
operated eight eye care centers in Indiana.
5. Effective July 1, 1997, the Company acquired all of the outstanding shares
of stock of Vision Holdings, Ltd. (formerly known as Dr. Greenberg, An
Optometry Corporation d/b/a/ Vision Plaza). At December 29, 2001, Vision
Plaza operated 14 primary eye care centers and one specialty eyewear
center in Louisiana and Mississippi.
6. The net loss and net loss per share in 1997 includes a $1,953,000 dividend
to the preferred stockholders.
7. Includes a $110,000 provision for store closings and $400,000 write off of
software development costs.
Item 7. Management's Discussion and Analysis of Financial Condition and Results
of Operation
Overview
The Company manufactures, distributes and sells eyewear and related
products and services. As of December 29, 2001, the Company's operations
consisted of 116 eye care centers, one optical laboratory and distribution
center, making it one of the fifteen largest providers in the United States
primary eye care industry based upon sales. The Company's eye care centers
operate primarily under the brand names Cambridge Eye Doctors, E.B. Brown
Opticians, Eyeglass Emporium, Vision Plaza, Vision World, Shawnee Optical and
Kent Optical. The Company also provides, or where necessary to comply with
applicable law, administers the business functions of optometrists,
ophthalmologists and professional corporations that provide, vision related
professional services.
The Company operates one optical laboratory and distribution center. The
regional optical laboratory provides complete services to the Company's eye care
centers, including polishing, cutting and edging, tempering, tinting and coating
of ophthalmic lenses. The distribution center provides and maintains an
inventory of all accessories and supplies necessary to operate an eye care
center, as well as "ready made" eye care products, including contact lenses and
related supplies. The inventory of eyeglass lenses, frames, contact lenses,
accessories and supplies is acquired through a number of sources, domestic and
foreign. Management believes that the optical laboratory and distribution center
has the capacity to accommodate additional multi-site eye care centers. In early
2001, the Company operated two regional optical laboratories and three
distribution centers. During 2001, one laboratory and two distribution centers
were closed and their operations were consolidated in the remaining laboratory
and distribution center. The laboratory and distribution centers were closed in
an effort for the Company to realize greater operating efficiencies from lower
inventories and lower payroll and related costs.
The Company's results of operations include the accounts of the Company,
its wholly-owned subsidiaries and four professional corporations ("PCs") in
which the Company's subsidiaries assume the financial risks and rewards of such
entities. The Company has no direct equity ownership in the PCs since the
outstanding voting capital stock of each of the PCs is 100% owned by a licensed
optometrist (the "nominee shareholder") who has, in turn, executed a Stock
Restrictions and Pledge Agreement (a "Pledge Agreement") in favor of a
subsidiary of the Company. Each Pledge Agreement contains
19
provisions that provide the Company with the ability at all times to cause a
change in the nominee shareholder for an unlimited number of times, at nominal
cost. For example, if (i) the employment of the nominee shareholder is
terminated by the PC or by the Company (including its subsidiaries) or (ii) the
Company determines that the nominee shareholder is impairing or rendering
less-than-optimal the Company's business management and administration of the
PC, then the Company has the right to require the existing nominee shareholder
to sell all of the outstanding stock of the PC to another person eligible to
serve as a new nominee shareholder. The purchase price for a sale of the PC's
stock is equal to the aggregate book value of the PC, which will always be a
nominal cost because each PC operates and expects to continue to operate at an
almost break-even level generating a nominal profit, if any at all. See
"Business--Current Operations-Stock Restrictions and Pledge Agreements."
Results of Operations 2001 as compared with 2000
Net Revenue. The Company generated net revenue of approximately $58.9
million during the year ended December 29, 2001 from operation of its 116 eye
care centers and its affiliated laser vision correction service as compared to
net revenue of approximately $64.2 million from the operation of its 122 eye
care centers and its affiliated laser vision correction service for the same
period in 2000. The $5.3 million or 8.3% decrease in total net revenue for the
year ended December 29, 2001 relates primarily to: (i) lower same store sales
during the first half 2001 of $2.3 million due to lower average sales and fewer
optometry patients; (ii) net revenue reduction of $1.9 million from the closing
of six stores; and (iii) one less week of sales (due to a 53 week fiscal year in
2000) at an average sales volume per week of $1.2 million. The remaining
difference is due to lower surgical services of $0.2 million due to increased
competition and lower prices. This is offset by higher same store sales during
the second half of 2001 of $0.3 million. The second half same store sales
reflects the loss of a large managed care contract in the Northeast effective
July 1, 2001 which adversely affected sales by approximately $0.2 million. This
contract is not expected to be replaced in the near future, if at all.
Cost of Revenue. Cost of revenue decreased to approximately $18.5 million
for the year ended December 29, 2001 as compared to $20.9 million for the year
ended December 30, 2000. Cost of revenue decreased as a percentage of net
revenue to 31.4% for the year ended December 29, 2001 from 32.6% for the year
ended December 30, 2000. The improvement as a percentage of net revenue
primarily reflects the realization of purchase economies from eyewear purchases
and the consolidation of the optical laboratory and distribution center
operations.
Selling, General and Administrative Expense. Selling, general and
administrative expenses decreased to approximately $44.2 million for the year
ended December 29, 2001 as compared to $46.2 million for the year ended December
30, 2000. The $2.0 million decrease relates primarily to: (i) one less week
during the 52-week fiscal year ended December 29, 2001 at an average weekly
expense volume of $0.9 million; (ii) lower store operating expenses of $0.4
million due to six fewer stores; (iii) lower depreciation expense of $0.4
million due to certain assets being fully depreciated; and (iv) lower corporate
expenses, mainly salaries and benefits due to fewer employees, of $0.6 million.
These lower expenses were offset in part by higher advertising expenses, mainly
in the second half of the year, of $0.6 million. The remainder of the decrease
of $0.3 million relates to several smaller expense reductions.
Non-recurring Severance and Consolidation Expense. During the second half
of 2001, the Company closed two distribution centers and one laboratory and
relocated its corporate headquarters from Holliston, Massachusetts to
Cincinnati, Ohio. Non-recurring severance and consolidation expenses of $0.8
million were incurred to facilitate these activities. In total, severance
incurred was $0.5 million, the buy-out of the Holliston office lease was $0.1
million and all other related expenses were $0.2 million.
20
Other Income and Expense. Interest expense decreased, net, to
approximately $0.8 million from $1.2 million for the years ended December 29,
2001 and December 30, 2000, respectively. The decrease is associated with lower
average interest rates during 2001 compared to 2000 and higher debt fees during
2000. Net disposition of assets in the year 2001 resulted in a loss of $67,000
as compared to a loss of $105,000 in 2000. The non-cash write off of deferred
financing costs in 2000 of approximately $60,000 as required by generally
accepted accounting principles was related to the execution of a loan
modification agreement with Fleet National Bank, dated March 31, 2000. The
reserve for notes receivable of $714,000 in 2000 resulted from the Company
providing a reserve for the amount of a note due from a former employee and
former member of the Board of Directors.
Dividends On Redeemable Convertible Preferred Stock. During 2001, the
Company recorded dividends on the redeemable convertible preferred stock of
$750,000 for dividends paid in the form of 1,221,999 shares of common stock and
the issuance of 1,000,000 common stock warrants.
Net Loss Attributable to Common Stockholders. The Company realized a net
loss attributable to common stockholders of approximately $6.2 million ($0.34
per share) and $5.1 million ($0.55 per share) for the years ended December 29,
2001 and December 30, 2000, respectively. The lower loss per share is due to the
increase in outstanding shares resulting from our merger with Eyeshop in July
2001 and its related stock purchase transactions.
Results of Operations 2000 as compared with 1999
Net Revenue. The Company generated net revenue of approximately $64.2
million during the year ended December 30, 2000 from the operation of its 122
eye care centers and laser vision correction affiliation as compared to net
revenue of approximately $67.0 million from the operation of its 130 eye care
centers and two laser vision correction centers in the United States for the
same period in 1999. The $2.8 million or 4.2% decrease in total net revenue for
the year ended December 30, 2000 relates primarily to lower average net sales
per store, lower laser vision revenues and the closing of eight stores net of
store additions. The decrease was partially offset by the fifty-three week
fiscal period ended December 30, 2000 as compared to the fifty-two week fiscal
period ended December 25, 1999 and also offset somewhat by the additional 37 eye
care centers acquired since April 1, 1999. The financial impact of the extra
week in the current year was approximately an additional $1.2 million of net
revenue.
Cost of Revenue. Cost of revenue decreased to approximately $20.9 million
for the year ended December 30, 2000 as compared to $22.8 million for the year
ended December 25, 1999. Cost of revenue decreased as a percentage of net
revenue to 32.6% for the year ended December 30, 2000 from 34% for the year
ended December 25, 1999. The improvement as a percentage of net revenue
primarily reflects the realization of purchase economies, consolidation of
optical laboratory operations, less sales price discounting, and, to a lesser
extent, small retail price increases.
Selling, General and Administrative Expense. Selling, general and
administrative expenses were approximately $46.2 million and $46.1 million for
the years ended December 30, 2000 and December 25, 1999, respectively. The
increase relates primarily to inflationary pressures that increased payroll and
occupancy costs, facility costs incurred in operating additional eye care
centers acquired since April 1, 1999, and the fifty-three week fiscal period in
2000 as compared to the prior year fifty-two week fiscal period, offset almost
entirely by reductions in bad debts, lower marketing expenditures and reduced
staffing levels.
Other Income and Expense. Interest income decreased to approximately
$52,000 from $82,000 for the years ended December 30, 2000 and December 25,
1999, respectively. This decrease resulted from
21
the investment of a lower average cash and cash equivalents balance during 2000
as compared to 1999. Interest expense increased to approximately $1.2 million
from $641,000 for the years ended December 30, 2000 and December 25, 1999,
respectively. The increase is associated with a higher average balance of debt
outstanding, higher average interest rates and higher debt fees during 2000 as
compared to 1999. Net disposition of assets in the year 2000 resulted in a loss
of $105,000 as compared to a gain of $16,000 in 1999. The non-cash write off of
deferred financing costs in 2000 of approximately $60,000 as required by
generally accepted accounting principles were related to the execution of a loan
modification agreement with Fleet National Bank dated March 31, 2000. The
non-cash write off of deferred financing costs in 1999 of approximately $323,000
was related to the execution of a new credit facility with Fleet National Bank
in April of 1999. The reserve for notes receivable of $714,000 in the year 2000
resulted from the Company providing a reserve for the amount of a note due from
a former employee and current member of the Board of Directors.
Net Loss Attributable to Common Stockholders. The Company realized a net
loss attributable to common stockholders of approximately $5.1 million ($0.55
per share) and $2.7 million ($0.30 per share) for the years ended December 30,
2000 and December 25, 1999, respectively.
Liquidity and Capital Resources
At December 29, 2001, the Company had approximately $1.4 million in cash
and cash equivalents and a working capital deficit of approximately $7.0 million
in comparison to approximately $0.5 million in cash and cash equivalents and
working capital deficit of approximately $6.3 million as of December 30, 2000.
The increase in working capital deficit is primarily due to the use of net
working capital to fund the Company's losses, offset in part by $1.75 million of
new equity raised in connection with our merger with Eyeshop (net of merger
related expenses). The largest portion of the net working capital deficit at
December 29, 2001 was debt of $8.2 million that matures on December 31, 2002.
The Company will need to raise additional funds during 2002 to replace maturing
bank debt and may seek to raise those funds through additional financings,
including public or private equity offerings. There can be no assurance that
such funds will be available on terms acceptable to the Company, if at all. If
adequate funds are not available, the Company may be required to limit its
operations, which would have a material and adverse affect on the Company. In
addition, in its report on the Company's consolidated financial statements, the
Company's independent auditors have expressed substantial doubt about the
Company's ability to continue as a going concern, due to the Company's recurring
losses and its potential inability to pay its outstanding debt.
On March 26, 2001, the Company entered into a Third Modification Agreement
(as defined below) with Fleet Bank that, among other things, extended the
maturity date of the loans to December 31, 2002. The Third Modification
Agreement required that the Company obtain equity financing in the amount of
$1.0 million by May 2001. On May 14, 2001, the Company entered into the Amended
and Restated Third Modification Agreement which extended the date for an equity
infusion from May 2001 to July 2001. In July 2001, the Company obtained equity
proceeds of $1.75 million.
Effective January 1, 1999, the Company acquired all of the outstanding
shares of capital stock of Shawnee Optical, Inc. The purchase price paid in
connection with this acquisition was $1.75 million in cash, $0.3 million in
notes payable over three years and 70,000 shares of common stock. In addition,
the Company agreed to issue additional consideration to the Shawnee stockholders
if the market price of the Company's common stock did not equal or exceed $5.00
per share at any time during the period from January 22, 2000 to January 22,
2001. The market price of the Company's common stock did not equal or exceed
$5.00 during such period. The amount of additional consideration due to the
Shawnee stockholders for each share of common stock issued in the acquisition
and held by them on
22
January 22, 2001 is equal to the difference between $5.00 and the greater of (a)
the market price on January 22, 2001 or (b) $2.45. As of January 22, 2001, the
aggregate additional consideration estimated to be payable to the Shawnee
sellers was $178,500. At the Company's option, the additional consideration may
be paid to the Shawnee stockholders in cash or in additional shares of the
Company's common stock valued at its market price on the date that the
additional consideration becomes payable to the Shawnee stockholders. As a
result of the Company's obligation to issue additional consideration to the
Shawnee stockholders, on March 20, 2001, the Company entered into a Settlement
Agreement and Mutual Release with the Shawnee stockholders in which the Company
agreed to issue 238,000 shares of its common stock to the Shawnee stockholders.
At the time of the acquisition, the Company included the value of this
additional consideration in its determination of the purchase price.
Effective April 1, 1999, the Company acquired all of the outstanding
shares of capital stock of Kent Optical Company and its associated companies.
The purchase price paid in connection with this acquisition was $5.209 million
in cash, $1.0 million in notes payable over three years and 160,000 shares of
common stock. In addition, the Company offered to issue additional consideration
to the Kent stockholders if the market price of the Company's common stock did
not equal or exceed $5.00 per share at any time during the period from April 23,
2000 to April 23, 2001. The market price of the Company's common stock did not
equal or exceed $5.00 per share from April 23, 2000 to April 25, 2001. The
amount of additional consideration due to the Kent stockholders for each share
of common stock issued in the acquisition and held by them on April 23, 2001 is
equal to the difference between $5.00 and the greater of (a) the market price of
the common stock on April 23, 2001 or (b) $2.73. At the Company's option, the
additional consideration may be paid to the Kent stockholders in cash or in
additional shares of the Company's common stock valued at its market price on
the date that the additional consideration becomes payable to the Kent
stockholders. At the time of acquisition, the Company included the value of this
additional consideration in its determination of the purchase price. On February
7, 2002 the Company entered into a settlement agreement with the former Kent
stockholders and agreed to pay such additional consideration by issuing
1,100,636 shares of its common stock. The shares were issued on February 27,
2002. Also, as part of this settlement, the Company renegotiated the terms of
the remaining amounts owed under the notes payable.
In connection with the exercise of stock options to purchase 138,332
shares (the "Option Shares") of the Company's common stock during fiscal 1997,
Stephen M. Blinn, a former executive officer and former Director of the Company,
executed a promissory note (the "Note") in favor of the Company for the
aggregate exercise price of $594,111. The Note is due on the earlier of
September 2, 2007 or the date upon which Mr. Blinn receives the proceeds of the
sale of not less than 20,000 of the Option Shares (the "Maturity Date").
Interest accrues at the rate of 6.55%, compounding annually, and is payable on
the earlier of the Maturity Date of the Note or upon certain Events of Default
as defined in the Note. The principal balance of the Note, together with accrued
and unpaid interest, was approximately $714,000 as of December 29, 2001. In
fiscal 2000, Mr. Blinn informed the Company that he understood that the terms of
the Note permitted Mr. Blinn to satisfy in full his obligations under the Note
by either (a) returning the Option Shares to the Company or (b) turning over to
the Company any cash proceeds received by Mr. Blinn upon a sale of the Option
Shares. The Company has informed Mr. Blinn that the Note is a full recourse
promissory note, and that Mr. Blinn remains personally liable for all unpaid
principal and interest under the Note. Due to Mr. Blinn's position regarding the
Note and his failure to provide the Company or the Company's accountants with a
copy of his personal financial statements or any other evidence of his ability
to pay the amounts due under the Note, the Company has established a $714,000
reserve in accordance with generally accepted accounting principles for notes
receivable and, subsequent to the establishment of the reserve, the Company no
longer recognizes interest income related to the Note. Despite the reserve, the
Company intends to take all measures necessary to collect the amounts due from
Mr. Blinn.
23
As of December 29, 2001, the Company had warrants outstanding which
provide it with potential sources of financing as outlined below. However,
because the current market value of the Company's common stock is significantly
less than or approximately equal to the exercise prices for such warrants, it is
unlikely that any subsequent proceeds may be realized by the Company.
Exercise
Potential Price
Securities Number Proceeds Per Share
---------- ------ --------- ---------
Carlyle Warrants ......................................... 1,000,000 $ 200,000 $ 0.20
Class II Warrants ........................................ 657,749 2,032,444 3.09
Bank Austria AG, f/k/a Creditanstalt, Warrants ........... 150,000 693,750 4.63
Fleet Warrants ........................................... 50,000 25,500 0.51
Fleet Warrants ........................................... 50,000 7,810 0.16
---------- ----------
1,907,749 $2,959,504
========== ==========
The Company also has outstanding 62,884 Class I Warrants. The Class I
Warrants entitle the holder to purchase an amount of shares of the Company's
common stock equal to an aggregate of up to 19.9% of the shares of common stock
purchasable under the Company's warrants and options outstanding as of October
9, 1997 on the same terms and conditions of such warrant and option holders. The
purchaser is obligated to exercise these warrants at the same time such options
and warrants of existing holders are exercised, subject to certain limitations.
The amount of proceeds from the exercise of these Class I Warrants cannot be
estimated at this time. However, for the same reasons stated above, it is
unlikely that any proceeds would be realized by the Company.
On February 20, 1997, the Company entered into a Credit Agreement (the
"1997 Agreement") with a bank pursuant to which the Company could borrow up to
$5.0 million on a term loan basis and up to $5.0 million on a revolving credit
basis subject to certain performance criteria. As part of the 1997 Agreement,
the Company issued to the bank warrants to purchase 150,000 shares of the
Company's common stock at a purchase price of $4.625 per share. The warrants
expire on December 31, 2003. As noted in the following paragraph, the Company
has entered into a new credit facility and retired the 1997 Agreement.
On April 15, 1999, the Company entered into a credit agreement (the "1999
Agreement") with Fleet National Bank ("Fleet") pursuant to which the Company
could borrow $10.0 million on an acquisition line of credit, of which $7.0
million is on a term loan basis and $3.0 million is on a revolving line of
credit basis, subject to certain performance criteria and an asset-related
borrowing base for the revolver. The performance criteria include, among others,
financial condition covenants such as net worth requirements, indebtedness to
net worth ratios, debt service coverage ratios, funded debt coverage ratios, and
pretax profit, net profit and EBITDA requirements. The acquisition line facility
bore interest at either Fleet's prime rate, or LIBOR plus 2.25%, or at a
comparable interest swap rate at the Company's election. The term loan facility
bore interest at LIBOR plus 2.25% or at a comparable interest swap rate at the
Company's election. The revolving credit facility bore interest at Fleet's prime
rate or LIBOR plus 2.0% at the Company's election.
At December 25, 1999, the Company was not in compliance with the following
financial covenants of the 1999 Agreement: minimum net worth, minimum debt
service coverage, maximum funded debt service coverage and minimum net profit.
However, on March 31, 2000, the Company and Fleet entered into a modification
agreement (the "Original Modification Agreement") that amended the 1999
Agreement in order to, among other things, waive the Company's default, adjust
certain covenants to which the Company is subject and terminate the acquisition
line of credit. In addition, the Original Modification Agreement limited the
revolving line note to $2.5 million and the term loan to $6.75 million
24
and established the maturity date for each of these credit lines as March 31,
2001. Also, the Original Modification Agreement established the following
interest rates for both the revolving line note and term loan: (i) from March
31, 2000 through August 31, 2000 - prime rate plus 1.0%; (ii) from September 1,
2000 through October 31, 2000 - prime rate plus 2.0%; and (iii) from November 1,
2000 through March 31, 2001 - prime rate plus 3.0%. The scheduled monthly
principal payments for the term loan have been adjusted to $83,333.33 from
April, 2000 through July, 2000, $100,000.00 from August, 2000 through December,
2000 and $125,000.00 from January, 2001 through March, 2001. As part of the
Original Modification Agreement, the Company issued to Fleet warrants to
purchase 50,000 shares of the Company's common stock at an exercise price of
$0.51 per share, which was equal to the average closing price of the common
stock for the last five trading days for the month of August of 2000, and
warrants to purchase 50,000 shares of the Company's common stock at an exercise
price of $0.156 per share, which was equal to the average closing price of the
Company's common stock for the last five trading days for the month of December
of 2000. In August 2000, as a result of a bank merger, Sovereign Bank of New
England ("Sovereign") became the successor party to Fleet in the 1999 Agreement
and the Original Modification Agreement.
On November 30, 2000, the Company and Sovereign entered into a second
modification agreement (the "Second Modification Agreement") that amended the
terms of the Original Modification Agreement in order to, among other things,
defer certain payments required under the term note and amend certain terms and
conditions of the 1999 Agreement. Sovereign deferred the required principal
payments due on December 1, 2000 in the amount of $100,000 and on January 1,
2001 in the amount of $125,000 until March 1, 2001 and March 22, 2001,
respectively. At December 30, 2000, the Company was in default for
non-compliance with certain negative covenants contained in the Second
Modification Agreement relating to minimum net worth, minimum debt service
coverage, maximum funded debt service coverage and minimum net profit.
On March 26, 2001, the Company and Sovereign entered into the Third
Modification Agreement (the "Third Modification Agreement") that amended the
terms of the Original Modification Agreement and the Second Modification
Agreement in order to, among other things, waive the Company's default, adjust
or delete certain covenants to which the Company was subject, change the
repayment terms and extend the maturity date of the loans to December 31, 2002.
In addition, the Third Modification Agreement required that the Company close an
equity financing of at least $1.0 million with third party investors on or
before May 31, 2001. The Third Modification Agreement established the following
annual interest rates for both the revolving line and term loans: (i) from
February 1, 2001 through September 30, 2001 - six (6%) percent, (ii) from
October 1, 2001 through December 31, 2001 - seven (7%) percent, (iii) from
January 1, 2002 through December 31, 2002 - prime rate subject to a minimum rate
of eight (8%) percent and a maximum rate of eleven (11%) percent. The scheduled
monthly principal payments did not begin until July 1, 2001 and were set as
$30,000 from July 1, 2001 through December 31, 2001, and $100,000 from January
1, 2002 through December 31, 2002. On May 14, 2001, the Company entered into the
Amended and Restated Third Modification Agreement which restated the terms
described above and extended the date for which the Company was required to
close an equity financing to July 2001. In August 2001, Sovereign sold the loan
back to Fleet.
As of December 29, 2001, the Company's outstanding indebtedness under the
1999 Agreement was $2.5 million under the revolver portion and $5.67 million
under the term portion.
The Company has obtained waivers from the bank for all breaches of loan
covenants to date, but the Company may not receive waivers for any future
25
breaches that may occur. Any breach that is not waived may result in the bank
declaring the breach to be a default under the 1999 Agreement, which would
require immediate repayment of all outstanding principal and accrued interest at
a time when the Company may not be able to repay the bank.
On May 23, 2001, the Company entered into a common stock purchase
agreement by and among the Company, Eyeshop and certain investors associated
with Eyeshop (the "Stock Purchase Agreement"), pursuant to which the Company
agreed to sell, in two tranches, an aggregate of 5,000,000 shares of its common
stock at a price of $0.20 per share for an aggregate purchase price of $1.0
million to persons associated with Eyeshop. The Company closed on the sale of
the first tranche of 1,250,000 shares for $250,000 on May 23, 2001 and on the
second tranche of 3,750,000 shares for $750,000 on July 20, 2001.
On July 20, 2001, pursuant to an Agreement and Plan of Merger (the "Merger
Agreement") dated as of May 23, 2001 by and among the Company, Eyeshop
Acquisition Corporation, a Delaware corporation and wholly-owned subsidiary of
the Company ("EAC"), and Eyeshop, EAC merged with and into Eyeshop (the
"Merger") and Eyeshop became a wholly-owned subsidiary of the Company.
Pursuant to the Merger Agreement, Eyeshop stockholders exchanged their
Eyeshop stock for the following at the closing of the Merger:
. Each outstanding share of Eyeshop common stock was exchanged for
4.52 shares of the Company's common stock;
. Each outstanding share of Eyeshop Series A Preferred Stock was
exchanged for 9.79 shares of the Company's common stock; and
. Each outstanding share of Eyeshop Series B Preferred Stock was
exchanged for 33.72 shares of the Company's common stock.
Pursuant to the Merger Agreement, former Eyeshop stockholders are also
entitled to receive additional shares of the Company's common stock if and when
the options, warrants and other rights to receive the Company's common stock
that were held by the Company's security holders as of May 23, 2001 are
exercised. The Company issued a total of 7,306,662 shares of Common Stock to
former Eyeshop stockholders in connection with the Merger. Concurrently with the
Eyeshop merger, the Company assumed outstanding options under the Eyeshop stock
option plan to purchase up to an aggregate of 1,757,096 shares of the Company's
common stock.
On May 31, 2001, the Company entered into a common stock purchase
agreement by and among the Company and certain investors associated with
Eyeshop, to sell an aggregate of 6,569,500 shares of its common stock at a price
of $0.20 per share for an aggregate purchase price of approximately $1.31
million. The Company closed on the sale of the these shares on July 20, 2001.
Contemporaneously with the closing of the Merger, the Company and Carlyle
Venture Partners, L.P., C/S Venture Investors, L.P., Carlyle U.S. Venture
Partners, L.P. and Carlyle Venture Coinvestment, L.L.C. (collectively, the
"Investors") entered into an agreement which provides for, among other things,
the following terms: i) that upon conversion of the Series B redeemable
convertible preferred stock, par value $0.01 per share (the "Preferred Stock"),
the Investors will be entitled to receive 3,176,511 shares of the Company's
common stock in satisfaction of the Investors' rights to receive anti-dilution
protection in connection with the financings and the Merger; ii) that the
Investors waived their rights to anti-dilution protection with respect to future
obligations of the Company to issue securities; iii) that the Investors waived
their rights to receive additional shares of common stock pursuant to the Class
I Warrants with respect to future issuances of warrants and options by the
Company, all in exchange for a warrant to purchase 1,000,000 shares of common
stock at an exercise price of $0.20 per share; iv) that the Company satisfy its
obligations to pay dividends on the Preferred Stock for the calendar year 2001
by issuing an aggregate of 1,221,999 shares of common stock in installments of
364,723 shares, 318,947 shares and 283,380 shares, all of which were issued on
August 30, 2001, and 254,949 shares, which were issued effective as of November
1, 2001; v) that dividends accruing on the Preferred Stock after November 1,
2001 will accrue as cash dividends and be paid promptly in cash upon the
earliest to occur of the merger, consolidation, reorganization,
recapitalization, dissolution or liquidation of the Company where the
stockholders of the Company immediately following the consummation of the merger
no longer own more than 50% of the voting securities of the Company, the sale,
lease, exchange or other transfer of all or substantially all of the assets of
the Company, the consummation of an equity financing by the Company in which
proceeds to the Company, net of transaction costs, are greater than or equal to
$10 million, the end of the first twelve month period in which earnings before
income taxes, depreciation and amortization are equal to or greater than $5.0
million dollars or the refinancing of the Company's outstanding indebtedness to
Fleet Bank; vi) and that the Investors waive their right to more than one
designee on the Company's board of directors.
Contractual Obligations
The following table of debt, operating lease obligations and capital lease
obligations at December 29, 2001, summarizes the effects these obligations are
expected to have on our cash flow in future periods as set forth below (in
thousands):
26
2002 2003 2004 2005 2006 Thereafter
------- ------ ------ ------ ------ ----------
Debt $ 8,479 $ 355 $ 374 $ 23 $ 23 $ 153
Operating Leases 5,694 4,696 3,593 2,831 2,144 2,400
Capital Leases 11 11 8 -- -- --
------- ------ ------ ------ ------ ------
Total $14,184 $5,062 $3,975 $2,854 $2,167 $2,553
======= ====== ====== ====== ====== ======
The Company will need to raise additional funds during 2002 to replace the
maturing bank debt and may seek to raise those funds through additional
financings, including public or private equity offerings.
Management's Discussion of Critical Accounting Policies
In December 2001, the Securities and Exchange Commission ("SEC") requested
that all registrants identify and describe their most "critical accounting
policies" in "Management's Discussion and Analysis of Financial Condition and
Results of Operations." The SEC indicated that a "critical accounting policy" is
one which is both important to the portrayal of the company's financial
condition and results and requires management's most difficult, subjective or
complex judgments, often as a result of the need to make estimates about the
effect of matters that are inherently uncertain. The Company believes that the
following of its accounting policies fit this definition:
Revenue Recognition and Allowance for Bad Debts
The Company recognizes revenue from the sale of eyewear at the time an
order is complete and revenue from eyecare services when the service is
performed. The Company has fee for service arrangements with most of its third
party payers. The Company recognizes revenue with third party payers net of
contractual allowances. There is very little management judgment used to
determine revenue.
Because of various circumstances, such as changes in third party plan
contractual allowances, changes in patient co-pays, and goods or services denied
by third party payers, the Company reviews the agings of receivables from third
party payers and patients on at least a monthly basis. Sometimes claims have
incomplete or inaccurate information, and the Company re-submits those claims to
the third party payer. If amounts are denied by the third party payer and the
Company has recourse to the patient, the Company pursues payment from the
patient. Based on the Company's history of collectibility of older third party
payer and patient receivables, the Company provides a substantial reserve for
uncollectibility. At December 29, 2001 and December 30, 2000 the Company had
reserved for 42% and 42%, respectively, of the gross amount of the outstanding
third party payer and patient receivables. If actual collectibility of these
receivables is significantly different from management's estimate, it could have
a material (favorable or unfavorable) result on the operating results and
liquidity of the Company.
27
Impairment of Long Lived Assets
The Company records impairment losses on long-lived assets when events and
circumstances indicate that the assets might be impaired and the undiscounted
cash flows estimated to be generated by those assets are less than the book
value of those items. The Company's cash flow estimates are based on historical
results adjusted to reflect the Company's best estimate of future market and
operating conditions. In performing this analysis, the Company considers such
factors as current results, trends and future prospects, in addition to other
economic factors. Based on those analyses during the years 1999 through 2001,
the Company did not record any charges for the impairment of long-lived assets.
At December 29, 2001, the Company had long-lived assets, including goodwill and
other intangibles, of $20.0 million, property and equipment of $2.7 million, and
web site development costs of $2.3 million.
Conditions that could cause future impairment are deterioration of
on-going or forecasted operating results resulting from increased competition, a
recession in the United States or lack of liquidity causing the Company to limit
its operations. If one or more of these conditions occur, future analysis
may indicate that certain long-lived assets are impaired, at which time the
Company would recognize an impairment charge. That impairment charge may be
material and have a significant impact on the Company's results of operations.
Further, the Company's web site development was acquired in the Eyeshop
merger. It was anticipated that, following the merger, available cash resources
of the combined companies would be devoted to continuation and improvement of
the business of the Company, with a decision to be made at a future date as to
when the Eyeshop web site development activities should be resumed. As of March
2002, no decision has been made to the timing of resuming Eyeshop web site
development activities. If the Company were to make a future decision to not
resume development of this web site, then it is possible that the Company may
have to recognize an impairment charge of up to the entire amount of $2.3
million and that charge may have a significant impact on the Company's results
of operations.
Income Taxes
The Company has a history of unprofitable operations and these losses have
generated a sizeable federal tax net operating loss, or NOL, carryforward of
approximately $28.0 million as of December 29, 2001. Generally accepted
accounting principles require that the Company records a valuation allowance
against the deferred tax asset associated with this NOL if it is "more likely
than not" that the Company will not be able to utilize it to offset future
taxes. Due to the size of the NOL carryforward in relation to the Company's
history of unprofitable operations, the Company has not recognized any of this
net deferred tax asset. The Company currently provides for income taxes only to
the extent that it expects to pay cash taxes (primarily state taxes) for current
income.
It is possible, however, that the Company could be profitable in the
future at levels which cause management to conclude that it is more likely than
not that the Company will realize all or a portion of the NOL carryforward. Upon
reaching such a conclusion, the Company would immediately record the estimated
net realizable value of the deferred tax asset at that time and would then
provide for income taxes at a rate equal to the Company's combined federal and
state effective rates, which would approximate 40% under current tax rates.
Subsequent revisions to the estimated net realizable value of the deferred tax
asset could cause the Company's provision for income taxes to vary significantly
from period to period, although the Company's cash tax payments would remain
unaffected until the benefit of the NOL is utilized.
28
Recent Accounting Pronouncements
In July, 2001, the FASB issued Statement No. 141, Business Combinations,
and Statement No. 142, Goodwill and Other Intangible Assets. Statement 141
requires that the purchase method of accounting be used for all business
combinations initiated after June 30, 2001 as well as all purchase method
business combinations completed after June 30, 2001. Statement 141 also
specifies the criteria intangible assets acquired in a purchase method business
combination must meet to be recognized and reported apart from goodwill, noting
that any purchase price allocable to an assembled workforce may not be accounted
for separately. Statement 142 will require that goodwill and intangible assets
with indefinite useful lives no longer be amortized, but instead tested for
impairment at least annually in accordance with the provisions of Statement 142.
Statement 142 will also require that intangible assets with definite useful
lives be amortized over their respective estimated useful lives to their
estimated residual values, and reviewed for impairment in accordance with
Statement 121, Accounting for the Impairment of Long-Lived Assets and for
Long-Lived Assets to be Disposed Of.
The Company was required to adopt the provisions of Statement 141
on July 1, 2001, and Statement 142 effective December 30, 2001. Furthermore, any
goodwill and any intangible assets determined to have an indefinite useful life
that are acquired in a purchase business combination completed after June 30,
2001 will not be amortized, but will continue to be evaluated for impairment in
accordance with the appropriate pre-Statement 142 accounting literature.
Goodwill and intangible assets acquired in business combinations completed
before July 1, 2001 will continue to be amortized prior to the adoption of
Statement 142. The Company's merger with Eyeshop on July 20, 2001, was not
subject to the provisions of Statement 141.
Statement 141 will require upon adoption of Statement 142 that the
Company evaluate its existing intangible assets and goodwill that were acquired
in a prior purchase business combination, and to make any necessary
reclassifications in order to conform with the new criteria in Statement 141 for
recognition apart from goodwill. Upon adoption of Statement 142, the Company
will be required to reassess the useful lives and residual values of all
intangible assets acquired in purchase business combinations, and make any
necessary amortization period adjustments by the end of the first interim period
after adoption, which was December 30, 2001 for the Company. In addition, to the
extent an intangible asset is identified as having an indefinite useful life,
the Company will be required to test the intangible asset for impairment in
accordance with the provisions of Statement 142 within the first interim period.
Any impairment loss will be measured as of the date of adoption and recognized
as the cumulative effect of a change in accounting principle in the first
interim period.
In connection with the transitional goodwill impairment evaluation,
Statement 142 will require the Company to perform an assessment of whether there
is an indication that goodwill (and equity-method goodwill) is impaired as of
the date of adoption. To accomplish this the Company must identify its reporting
units and determine the carrying value of each reporting unit by assigning the
assets and liabilities, including the existing goodwill and intangible assets,
to those reporting units as of the date of adoption. The Company will then have
up to six months from the date of adoption to determine the fair value of each
reporting unit and compare it to the reporting unit's carrying amount. To the
extent a reporting unit's carrying amount exceeds its fair value, an indication
exists that the reporting unit's goodwill may be impaired and the Company must
perform the second step of the transitional impairment test. In the second step,
the Company must compare the implied fair value of the reporting unit's
goodwill, determined by allocating the reporting unit's fair value to all of its
assets (recognized and unrecognized) and liabilities in a manner similar to a
purchase price allocation in accordance with
29
Statement 141, to its carrying amount, both of which would be measured as of the
date of adoption, which is December 30, 2001 for the Company. This second step
is required to be completed as soon as possible, but no later than the end of
the year of adoption. Any transitional impairment loss will be recognized as the
cumulative effect of a change in accounting principle in the Company's statement
of earnings.
And finally, any unamortized negative goodwill (and negative equity-method
goodwill) existing at the date Statement 142 is adopted must be written off as
the cumulative effect of a change in accounting principle.
As of the date of adoption of Statement 142, the Company expects to have
unamortized goodwill in the amount of $14.3 million, unamortized identifiable
intangible assets in the amount of $5.3 million and no unamortized negative
goodwill, all of which will be subject to the transition provisions of Statement
142. Amortization expense related to goodwill was $1.1 million for each of the
years ended December 29, 2001 and December 30, 2000. Because of the extensive
effort needed to comply with adopting Statement 144, it is not practicable to
reasonably estimate the impact of adopting the Statement on the Company's
financial statements on the date of this report, including whether any
transitional impairment losses will be required to be recognized as the
cumulative effect of a change in accounting principle.
In August, 2001, the FASB issued Statement 144, Accounting for the
Impairment or Disposal of Long-Lived Assets. Statement 144 addresses financial
accounting and reporting for the impairment or disposal of long-lived assets.
This Statement requires that long-lived assets be reviewed for impairment
whenever events or changes in circumstances indicate that the carrying amount of
an asset may not be recoverable. Recoverability of assets to be held and used is
measured by a comparison of the carrying amount of an asset to future net cash
flows expected to be generated by the asset. If the carrying amount of an asset
exceeds its estimated future cash flows, an impairment charge is recognized by
the amount by which the carrying amount of the asset exceeds the fair value of
the asset. Statement 144 requires companies to separately report discontinued
operations and extends that reporting to a component of an entity that either
has been disposed of (by sale, abandonment, or in a distribution to owners) or
is classified as held for sale. Assets to be disposed of are reported at the
lower of the carrying amount or fair value less costs to sell. The Company was
required to adopt Statement 144 on December 30, 2001. The Company believes that
the impact of adopting Statement 144 will not have a material impact on its
consolidated financial statements.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
The Company has not entered into any transactions using derivative
financial instruments or derivative commodity instruments and believes that its
exposure to market risk associated with other financial instruments (such as
investments) is not material.
Approximately $8.0 million of the Company's debt is subject to a floating
interest rate and every 1% increase in the relevant interest rate would
adversely affect the Company by $80,000.
30
Item 8. Financial Statements and Supplementary Data
INDEPENDENT AUDITORS' REPORT
The Board of Directors and Stockholders
Sight Resource Corporation:
We have audited the accompanying consolidated balance sheets of Sight
Resource Corporation and its subsidiaries as of December 29, 2001 and December
30, 2000, and the related consolidated statements of operations, stockholders'
equity, and cash flows for each of the years in the three-year period ended
December 29, 2001. These consolidated financial statements are the
responsibility of the Company's management. Our responsibility is to express an
opinion on these financial statements based on our audits.
We conducted our audits in accordance with auditing standards generally
accepted in the United States of America. Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above
present fairly, in all material respects, the financial position of Sight
Resource Corporation and its subsidiaries at December 29, 2001 and December 30,
2000, and the results of their operations and their cash flows for each of the
years in the three-year period ended December 29, 2001 in conformity with
accounting principles generally accepted in the United States of America.
The accompanying financial statements have been prepared assuming that the
Company will continue as a going concern. As discussed in Note 3 to the
financial statements, the Company's recurring losses and its ability to pay its
outstanding debt raise substantial doubt about its ability to continue as a
going concern. Management's plan in regard to this matter is also described in
Note 3. The consolidated financial statements do not include any adjustments
that might result from the outcome of this uncertainty.
/S/ KPMG LLP
Boston, Massachusetts
March 21, 2002
31
SIGHT RESOURCE CORPORATION
CONSOLIDATED BALANCE SHEETS
Dec. 29, Dec. 30,
2001 2000
---- ----
(in thousands except
for share amounts)
ASSETS
Current assets:
Cash and cash equivalents .................................................... $ 1,356 $ 532
Accounts receivable, net of allowance of $1,915 and $1,897 respectively ...... 2,613 2,587
Inventories .................................................................. 4,666 5,977
Prepaid expenses and other current assets .................................... 395 457
-------- --------
Total current assets .................................................... 9,030 9,553
-------- --------
Property and equipment, net (note 4) .............................................. 2,729 3,984
-------- --------
Other assets:
Intangible assets (note 5) ................................................... 19,770 21,444
Web site development (note 2) ................................................ 2,288 --
Other assets ................................................................. 127 158
-------- --------
Total other assets ...................................................... 22,185 21,602
-------- --------
$ 33,944 $ 35,139
-------- --------
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Revolver notes payable (note 6) .............................................. $ 2,500 $ 2,500
Current portion of long term debt (note 6) ................................... 5,979 6,540
Current portion of capital leases (note 7) ................................... 10 10
Accounts payable ............................................................. 5,789 4,721
Accrued expenses (note 8) .................................................... 1,813 2,007
Dividends .................................................................... -- 51
-------- --------
Total current liabilities ............................................... 16,091 15,829
-------- --------
Non-current liabilities:
Long term debt, less current maturities (note 6) ............................. 928 451
Capital leases (note 7) ...................................................... 17 25
-------- --------
Total non-current liabilities ........................................... 945 476
-------- --------
Series B redeemable convertible preferred stock 1,452,119 shares issued (note 9) .. 6,535 6,535
-------- --------
Stockholders' equity (note 10):
Preferred Stock, $.01 par value. Authorized 5,000,000 shares;
no shares of Series A issued and outstanding ................................. -- --
Common stock, $.01 par value. Authorized 50,000,000 shares; issued 29,597,703
and 9,261,552 shares in 2001 and 2000, respectively ......................... 296 93
Additional paid-in capital ........................................................ 41,810 38,452
Treasury stock at cost (30,600 shares in 2000 and 1999) ........................... (137) (137)
Accumulated deficit ............................................................... (31,596) (26,109)
-------- --------
Total stockholders' equity .............................................. 10,373 12,299
-------- --------
$ 33,944 $ 35,139
======== ========
See accompanying notes to consolidated financial statements.
32
SIGHT RESOURCE CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
Years Ended December
--------------------
2001 2000 1999
---- ---- ----
(in thousands except for per
share amounts)
Net revenue ................................................... $ 58,949 $ 64,219 $ 67,034
Cost of revenue ............................................... 18,526 20,929 22,823
-------- -------- --------
Gross margin ........................................ 40,423 43,290 44,211
Selling, general and administrative expense ................... 44,230 46,155 46,122
Non-recurring severance and consolidation expenses (note 11) .. 773 -- --
-------- -------- --------
Loss from operations ................................ (4,580) (2,865) (1,911)
-------- -------- --------
Other income (expense):
Interest expense, net .................................... (754) (1,180) (559)
Gain (loss) on disposal of assets ........................ (67) (105) 16
Write-off of deferred financing cost ..................... -- (60) (323)
Reserve for note receivable .............................. -- (714) --
-------- -------- --------
Total other (expense) ............................... (821) (2,059) (866)
-------- -------- --------
Loss before income tax expense ...................... (5,401) (4,924) (2,777)
Income tax expense (note 13) .................................. 86 80 77
-------- -------- --------
Net loss ............................................ $ (5,487) $ (5,004) $ (2,854)
======== ======== ========
(Dividends on) adjustment to cost of redeemable convertible
preferred stock (note 9) ...................................... (750) (51) 142
-------- -------- --------
Net loss attributable to common shareholders .................. $ (6,237) $ (5,055) $ (2,712)
======== ======== ========
Basic and diluted loss per common share (note 2) .............. $ (0.34) $ (0.55) $ (0.30)
======== ======== ========
Weighted average number of common shares outstanding .......... 18,490 9,228 9,181
======== ======== ========
See accompanying notes to consolidated financial statements.
33
SIGHT RESOURCE CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
Years Ended December 29, 2001, December 30, 2000 and December 25, 1999
----------------------------------------------------------------------
Common Stock
------------
Additional Common Total
Par Paid-in Accum. Stock Treasury Unearned Stockholder's
Shares Value Capital Deficit Issuable Stock Comp. Equity
------ ----- ------- ------- -------- ----- ----- ------
(in thousands)
Balance, December 31, 1998 ... 8,936 $ 90 $ 36,847 $(18,251) $ 432 $(137) $(22) $ 18,959
Exercise of stock options
(notes 10 & 14) ............ 5 -- 2 -- -- -- -- 2
Issuance of Common Stock
for acquisitions ........... 316 3 1,509 -- (432) -- -- 1,080
Adjustment to cost of
Preferred stock issuance ..... -- -- 142 -- -- -- -- 142
Amortization of unearned
compensation ............... -- -- -- -- -- -- 20 20
Net loss ..................... -- -- -- (2,854) -- -- -- (2,854)
------ ---- -------- -------- ----- ----- ---- --------
Balance, December 25, 1999 ... 9,257 93 38,500 (21,105) 0 (137) (2) 17,349
Exercise of stock options
(notes 10 & 14) ............ 5 -- 3 -- -- -- -- 3
Dividends .................... -- -- (51) -- -- -- -- (51)
Amortization of unearned
compensation ............... -- -- -- -- -- -- 2 2
Net loss ..................... -- -- -- (5,004) -- -- -- (5,004)
------ ---- -------- -------- ----- ----- ---- --------
Balance, December 30, 2000 ... 9,262 93 38,452 (26,109) 0 (137) (0) 12,299
Issuance of Common Stock
for acquisitions (Shawnee
make good) ................. 238 2 (2) -- -- -- -- --
Issuance of common shares
for merger with Eyeshop .... 7,306 73 1,981 -- -- -- -- 2,054
Issuance of common shares
for cash ................... 11,570 116 1,637 -- -- -- -- 1,753
Dividends in stock and
warrants to preferred
stockholder ................ 1,222 12 (258) -- -- -- -- (246)
Net Loss ..................... -- -- -- (5,487) -- -- -- (5,487)
------ ---- -------- -------- ----- ----- ---- --------
Balance, December 29, 2001 ... 29,598 $296 $ 41,810 $(31,596) $ 0 $(137) $ 0 $ 10,373
====== ==== ======== ======== ===== ===== ==== ========
See accompanying notes to consolidated financial statements
34
SIGHT RESOURCE CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
2001 2000 1999
------- ------- -------
Operating activities:
Net loss ..................................................................... $(5,487) $(5,004) $(2,854)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization ........................................... 3,401 3,844 3,828
Amortization and write off of deferred financing costs .................. 111 297 353
Amortization of unearned compensation ................................... -- 2 20
(Gain)/loss on disposal of assets ....................................... 71 105 (16)
Reserve for note receivable ............................................. -- 714 --
Changes in operating assets and liabilities:
Accounts receivable ..................................................... (26) 996 448
Inventories ............................................................. 1,311 898 (1,012)
Prepaid expenses and other current assets ............................... (62) (113) 65
Accounts payable and accrued expenses ................................... 594 (551) (1,204)
------- ------- -------
Net cash provided by (used in) operating activities ................ (87) 1,188 (372)
------- ------- -------
Investing activities:
Purchases of property and equipment ..................................... (480) (681) (1,513)
Payments for acquisitions, net of cash acquired ......................... -- -- (6,419)
Proceeds from sale of assets ............................................ 2 169 115
Other assets ............................................................ (80) (248) 362
------- ------- -------
Net cash used in investing activities .............................. (558) (760) (7,455)
------- ------- -------
Financing activities:
Principal payments on debt .............................................. (260) (1,568) (2,961)
Proceeds from issuance of stock ......................................... 1,753 -- --
Merger related expenses ................................................. (100) -- --
Proceeds from exercise of warrants and stock options .................... -- 3 2
Proceeds from bank loans ................................................ 76 1,525 9,234
Payment of other liabilities ............................................ -- (22) (142)
------- ------- -------
Net cash provided by (used in) financing activities ................ 1,469 (62) 6,133
------- ------- -------
Net increase (decrease) in cash and cash equivalents ......................... 824 366 (1,694)
Cash and cash equivalents, beginning of period ............................... 532 166 1,860
------- ------- -------
Cash and cash equivalents, end of period ..................................... $ 1,356 $ 532 $ 166
======= ======= =======
See note 14 for supplementary cash flow information. See
accompanying notes to consolidated financial statements.
35
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 29, 2001, December 30, 2000 and December 25, 1999
(1) The Company
(a) Nature of Business
Sight Resource Corporation (the "Company") manufactures, distributes and
sells eyewear and related products and services.
(b) Acquisitions
Effective January 1, 1999, the Company acquired all of the outstanding
shares of stock of Shawnee Optical, Inc. ("Shawnee"). The purchase price paid in
connection with this acquisition was $1,750,000 in cash, $300,000 in notes
payable over three years and 70,000 shares of common stock. Shawnee operated
nine eye care centers in Pennsylvania and Ohio. The acquisition was accounted
for using the purchase method of accounting.
With respect to the shares of common stock issued in the acquisition of
Shawnee, the Company agreed to issue additional consideration to the sellers if
the market price of the Company's common stock did not equal or exceed $5.00 per
share at any time during the period from January 22, 2000 to January 22, 2001.
The market price of the common stock did not equal or exceed $5.00 during such
period. On March 20, 2001, the Company entered into a Settlement Agreement and
Mutual Release with the Shawnee Stockholders in which the Company agreed to
issue 238,000 shares of its common stock as additional consideration in
connection with obligations incurred in the acquisition.
In early 1999, the Company provided a purchase accounting reserve of
$400,000 for the closing of two stores and one laboratory in Erie for Shawnee
and a reserve of $50,000 to sever administrative, store laboratory personnel.
During 1999, the Company revised the plan and determined no stores or
laboratories would be closed. At December 25, 1999, the Company finalized its
plan and also determined that no employees would be severed. The entire $450,000
acquisition reserve was reversed against goodwill and no reserves for Shawnee
exist December 25, 1999. No amounts were charged against acquisition reserves.
Effective April 1, 1999, the Company acquired all of the outstanding
shares of stock of Kent Optical, Inc. and its associated companies (collectively
"Kent"). The purchase price paid in connection with this acquisition was
$5,209,000 in cash, $1,000,000 in notes payable over three years and 160,000
shares of common stock. The Company anticipated that the aggregate additional
consideration estimated to be payable to the Kent sellers on April 23, 2001
would be $363,200. At the Company's option, the additional consideration could
be paid to the Kent stockholders in cash or in additional shares of the
Company's common stock valued at the its market price on the date that the
additional consideration became payable to the Kent stockholders. At the time of
acquisition, the Company included the value of this additional consideration in
its determination of the purchase price. Kent operated 28 eye care centers in
Michigan. The acquisition was accounted for using the purchase method of
accounting. In connection with the acquisition, the Company recorded purchase
accounting adjustments to increase liabilities and establish reserves for the
closing of facilities and related restructuring costs, including lease
commitments and severance costs. Total preliminary acquisition reserves at
December 25, 1999 were
36
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(Continued)
$91,500. During 2000, the Company charged $46,000 against the reserve for costs
to terminate store personnel. During 2001, the Company charged $45,500 against
the reserve for costs to terminate laboratory personnel. At December 29, 2001,
the purchase reserve balance is zero.
With respect to the shares of common stock issued in the acquisition of
Kent, the Company agreed to issue additional consideration to the sellers if the
market price of the Company's common stock does not equal or exceed $5.00 per
share at any time during the period from April 23, 2000 to April 23, 2001. From
April 23, 2000 to date, the market price of the Company's common stock has not
equaled or exceeded $5.00 per share. At the time of these acquisitions, the
Company included the value of this additional consideration in its determination
of the purchase price. On February 7, 2002 the Company entered into a settlement
agreement with the former Kent stockholders and agreed to pay such additional
consideration of $363,200 by issuing 1,100,606 shares of the Company's stock.
The shares were issued on February 27, 2002.
As a result of the acquisitions, the Company has also recorded adjustments
to increase liabilities and establish reserves for the closing of stores and
related restructuring costs, including lease commitments and severance costs.
The following unaudited pro forma financial information gives effect to
the acquisitions of Kent was effective January 1, 1999.
These pro forma results have been prepared for comparative purposes only
and do not purport to be indicative of the results of operations which actually
would have resulted had the acquisitions occurred on the date indicated, or
which may result in the future.
1999
----
(in thousands except for
per share data)
Revenue .................................................. $ 69,589
========
Net loss ................................................. $ (3,227)
========
Basic and Diluted loss per share ......................... $ (0.37)
========
Weighted average number of common shares outstanding ..... 9,341
========
The above unaudited pro forma financial information reflects certain
adjustments, including amortization of goodwill, and an increase in the weighted
average shares outstanding. This pro forma information does not necessarily
reflect the results of operations that would have occurred had the acquisition
taken place at the beginning of 1999 and is not necessarily indicative of
results that may be obtained in the future.
37
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(Continued)
In July 2001, the Company merged with eyeshop.com inc. ("Eyeshop"), an
early-stage optical development company established by E. Dean Butler in late
1999. Concurrent with the merger, there were two Common Stock Purchase
Agreements whereby the former shareholders of Eyeshop purchased additional
shares of the Company. It was anticipated that, following the merger, available
cash resources of the combined companies would be devoted to continuation and
improvement of the business of the Company, with a decision to be made at a
future date as to when the Eyeshop web site development activities should be
resumed. As of March 2002, no decision had been made to resume Eyeshop web site
development activities.
Pursuant to the Merger Agreement, former Eyeshop stockholders are also
entitled to receive additional shares of the Company's common stock if and when
certain options, warrants and other rights to receive the Company's common stock
that were held by the Company's security holders as of May 23, 2001 are
exercised. The Company issued a total of 7,306,662 shares of common stock to
former Eyeshop stockholders and assumed 1,757,096 stock options in connection
with the Merger. At the close of the Merger, former Eyeshop stockholders and
purchasers of the Company's common stock pursuant to the First Stock Purchase
Agreement held approximately 50% of the issued and outstanding common stock of
the Company.
Collectively, the former stockholders of Eyeshop together with the common
stock purchasers associated with Eyeshop held approximately 18,876,162 shares of
the Company's common stock immediately after the Merger and the common stock
financings, or approximately 64% of the Company's issued and outstanding common
stock and approximately 61% of the Company's issued and outstanding voting
securities.
The Company has completed its accounting for the Merger. The treatment,
for accounting purposes, was considered to be a purchase of Eyeshop's assets and
assumption of Eyeshop's liabilities by the Company. The aggregate purchase price
was $2,054,000 and the costs of the assets acquired and liabilities assumed have
been allocated on the basis of the estimated fair value of the net assets
required. There was no goodwill provided in the transaction.
The results of operations of the acquisitions and merger with Eyeshop have
been included in the consolidated financial statements from their respective
dates. The excess of the purchase price and expenses associated with each
acquisition, except the merger with Eyeshop, over the estimated fair value of
the net assets acquired has been recorded as goodwill.
(2) Summary of Significant Accounting Policies
(a) Principles of Consolidation
The Company's results of operation include the accounts of the Company,
its wholly-owned subsidiaries and four professional corporations ("PCs")
in which the Company's subsidiaries assume the financial risks and rewards
of such entities. The Company has no direct equity ownership in the PCs
since the outstanding voting capital stock of each of the PCs is 100%
owned by a licensed optometrist (the "nominee shareholder") who has, in
turn, executed a Stock Restrictions and Pledge
38
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(Continued)
Agreement ("Pledge Agreement") in favor of a subsidiary of the Company.
Each Pledge Agreement contains provisions that provide the Company with
the ability at all times to cause a change in the nominee shareholder and
for an unlimited number of times, at nominal cost. The purchase price for
a sale of the PC's stock is equal to the aggregate book value of the PC,
which will always be a nominal cost because each PC operates at an almost
break-even level generating a nominal profit, if any at all. All
significant intercompany balances and transactions have been eliminated.
(b) Cash and Cash Equivalents
Cash and cash equivalents consist of cash in banks and short-term
investments with original maturities of three months or less.
(c) Financial Instruments
The carrying amount of cash and cash equivalents, accounts receivable,
accounts payable and accrued expenses approximate fair value because of
the short maturity of these items. The carrying amount of other long-term
maturities approximates fair value. The carrying amount of the Company's
revolving line of credit and bank term loan approximates fair value
because the borrowing rate changes with market interest rates and the
short maturity of these items.
(d) Revenue Recognition
Revenue and the related costs from the sale of eyewear are recognized at
the time an order is complete. Revenue from eye care services is
recognized when the service is performed. The Company has fee for service
arrangements with most of its third party payors. Revenue is reported net
of contractual allowances.
Under revenue sharing arrangements for refractive surgery where the
Company is not responsible for patient billing, the Company receives a
specified payment from the hospital or center for each refractive surgical
procedure performed. Accordingly, the Company recognizes revenue on a per
procedure basis at the time procedures are performed. Under
revenue-sharing arrangements for refractive surgery where the Company is
responsible for the collection from the patient and payment to the
ophthalmologist and other operating costs, the total patient charge is
recorded as revenue with the corresponding expenses recorded in cost of
revenue.
(e) Inventories
Inventories primarily consist of the costs of eyeglass frames, contact
lenses, ophthalmic lenses, sunglasses and other optical products and are
valued at the lower of cost (using the first-in, first-out method) or
market.
(f) Property, Equipment and Long-Lived Assets
Property, equipment and long-lived assets are stated at cost. The Company
provides for depreciation at the time the property, equipment and
long-lived assets are placed in service. The straight-line method is used
over the estimated useful life of the assets. The Company accounts for
long-lived
39
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(Continued)
assets in accordance with the provisions of SFAS No. 121. This Statement
requires that long-lived assets be reviewed for impairment whenever events
or changes in circumstances indicate that the carrying amount of an asset
may not be recoverable. Recoverability of assets to be held and used is
measured by a comparison of the carrying amount of an asset to anticipated
profits and future undiscounted cash flows expected to be generated by the
asset. In performing this analysis, management considers such factors as
current results, trends, and future prospects, in addition to other
economic factors. If such assets are considered to be impaired, the
impairment to be recognized is measured by the amount by which the
carrying amount of the assets exceeds the fair value of the assets. Assets
to be disposed of are reported at the lower of the carrying amount or fair
value less costs to sell.
(g) Advertising
Advertising costs are expensed when incurred.
(h) Intangible Assets
Intangible assets resulting from the business acquisitions consist of
customer lists, trademarks, non-compete agreements, database/records and
the excess cost of the acquisition over the fair value of the net assets
acquired (goodwill). Certain values assigned are based upon independent
appraisals and are amortized on a straight line basis over a period of 5
to 25 years. The Company assesses the recoverability of unamortized
intangible assets on an ongoing basis by comparing anticipated operating
profits and future, undiscounted cash flows to net book value. In
performing this analysis, management considers such factors as current
results, trends, and future prospects, in addition to other economic
factors. Based on our analysis, no impairment existed at December 29, 2001
and December 30, 2000. Conditions that could cause future impairment are
deterioration of on-going or forecasted operating results caused by
increased competition, a recession in the United States or lack of
liquidity causing the Company to limit its operations.
(i) Income Taxes
The Company follows the asset and liability method of accounting for
income taxes and records deferred tax assets and liabilities based on
temporary differences between the tax bases of assets and liabilities and
their carrying amounts for financial statement purposes.
(j) Stock Options
The Company applies APB Opinion No. 25 and related interpretations in
accounting for stock options and as a result no compensation expense has
been recorded for granted options. The Company discloses in Note 10 the
impact if the Company had determined its compensation costs consistent
with FASB Statement No. 123.
40
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(Continued)
(k) Deferred Revenue
The Company offers a contact lens purchasing program in which, for a set
fee, customers may purchase contacts at discounted rates for a 12 month
period. The Company recognizes revenue from the sales of its contact lens
purchasing program on a monthly basis over the life of the program.
(l) Net Loss Per Share
Earnings per share are computed based on Statement of Financial Accounting
Standards No. 128 "Earnings per Share" ("SFAS 128"). SFAS 128 requires
presentation of basic earnings per share ("Basic EPS") and diluted
earnings per share ("Diluted EPS") by all entities that have publicly
traded common stock or potential common stock (options, warrants,
convertible securities or contingent stock arrangements). Basic EPS is
computed by dividing income attributable to common stockholders by the
weighted average number of common shares outstanding during the period.
The computation of diluted EPS does not assume conversion, exercise or
contingent exercise of securities that would have an antidilutive effect
on earnings.
The options, warrants and convertible preferred stock discussed in Notes 9
and 10 were not included in the computation of diluted Earnings Per Share
because the effect would be antidilutive.
(m) Web Site Development
The Company's web site development relates to that acquired as part of
the Eyeshop merger. Eyeshop capitalized costs incurred in connection
with the application development of the web site and underlying
software, including design and configuration, coding and testing.
Costs incurred during the preliminary project stage, including
conceptualization, evaluation and determination of existence of needed
technology, were expensed. Amortization of these amounts will begin
once the web site is fully functional.
(n) Use of Estimates
In preparation of these consolidated financial statements in conformity
with accounting principles generally accepted in the United States of
America, management of the Company has made estimates and assumptions that
affect the reported amounts of assets and liabilities, such as accounts
receivable, inventory, impairment of property and equipment and
intangibles. Actual results could differ from those estimates.
(3) Liquidity
The Company's primary loan facilities matures at December 31, 2002 and it
may be difficult to obtain financing or refinancing at terms acceptable to the
Company given the substantial historical losses. As of December 29, 2001, the
Company owed Fleet Bank $2.5 million under a revolving loan and $5.7 million
under a term loan (see Note 6). Interest rates on the loans during 2002 is at
prime rate with a minimum of 8% and a maximum of 11% The principal payments
during 2002 on the term loan are $100,000 per month. If the Company is not
successful in refinancing this debt, it may pursue additional equity
investments.
Given the Company's history, including substantial historical losses, the
Company may not be able to obtain financing or refinancing at terms acceptable
to the Company. The Company is making every effort to refinance these loans on
terms that are acceptable to the Company. The failure to obtain additional
financing would result in the declaration of a default with such loan facilities
and could materially and adversely affect our business and financial condition.
Any additional equity financing, if available, may be dilutive to our
stockholders and any debt financing, if available, may involve restrictions on
our financing and operating activities.
41
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(Continued)
(4) Property and Equipment
Property and equipment consists of the following:
Years Ended December
--------------------
(in thousands)
Estimated
2001 2000 Useful Life
---- ---- -----------
Land and building ................. $ 87 $ 87 40 years
Equipment ......................... 3,052 3,032 3-5 years
Computer equipment ................ 1,580 1,385 3 years
Furniture and fixtures ............ 1,855 1,836 3 years
Leasehold improvements ............ 4,679 4,704 Life of lease
------- -------
11,253 11,044
Less accumulated depreciation ..... 8,524 7,060
------- -------
Property and equipment, net ....... $ 2,729 $ 3,984
======= =======
(5) Intangible Assets
Intangible assets consists of the following:
Years Ended December
--------------------
(in thousands)
Estimated
2001 2000 Useful Life
---- ---- -----------
Goodwill ........................... $18,507 $18,507 20-25
Customer lists ..................... 5,932 5,932 11-15
Trademarks ......................... 1,823 1,773 15-20
Non-compete ........................ 380 380 5-10
Database/records ................... 310 310 12
------- -------
26,952 26,902
Accumulated amortization ........... 7,182 5,458
------- -------
Total ......................... $19,770 $21,444
======= =======
The useful lives of the above intangible assets are estimated based upon,
among other things, independent appraisals, history of operations acquired,
terms of agreements and industry standards.
42
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(Continued)
(6) Debt
Years Ended December
--------------------
(in thousands)
2001 2000
------ ------
Short-term borrowings consist of the following:
Bank revolver loan payable, variable interest rate (7% at 12/29/01),
interest due monthly $2,500 $2,500
====== ======
Long-term debt consists of the following:
Bank term loan payment, variable interest rate (7% at 12/29/01),
principal and interest due monthly 5,670 5,850
Unsecured notes payable, 5.1% interest rate, principal and interest
due monthly until December, 2004 (see Note 17) 767 667
Unsecured notes payable, 7.5% interest rate, principal due annually
and interest due quarterly 200 200
Unsecured notes payable, with interest rates of between 8 and 9%,
principal and interest due monthly until June 2010 213 209
Unsecured note payable, 7% interest rate, principal and interest due
quarterly until March 31, 2011 57 58
Unsecured note payable, 12% interest rate, principal and interest due
monthly until January 2001 -- 7
------ ------
$6,907 $6,991
Less current maturities 5,979 6,540
------ ------
Long term debt, less current maturities $ 928 $ 451
====== ======
On April 15, 1999, the Company entered into a Credit Agreement (the "1999
Agreement") with Fleet Bank ("Fleet") pursuant to which the Company can borrow
$10.0 million on an acquisition line of credit, $7.0 million on a term loan
basis and $3.0 million on a revolving line of credit basis, subject to certain
performance criteria and an asset-related borrowing base for the revolver. This
Credit facility is collateralized by substantially all of the Company's assets.
The performance criteria include, among others, financial condition covenants
such as net worth requirements, indebtedness to net worth ratios, debt service
coverage ratios, funded debt coverage ratios, and pretax profit, net profit and
EBITDA requirements. The acquisition line facility bears interest at either the
bank's prime rate, or LIBOR plus 2.25%, or at a comparable interest swap rate at
the Company's election.
The term loan facility bears interest at LIBOR plus 2.25% or at a
comparable interest swap rate at the Company's election. The revolving credit
facility bears interest at the bank's prime rate or LIBOR plus 2.0% at the
Company's election. Amounts borrowed under the 1999 Agreement were used to
finance acquisitions, retire existing bank debt, provide ongoing working capital
and/or for other general corporate purposes.
On March 31, 2000, the Company and Fleet entered into a modification
agreement (the "Original Modification Agreement") that amended the 1999
Agreement in order to, among other things, waive the Company's default, adjust
certain covenants to which the Company is subject and terminate the
43
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(Continued)
acquisition line of credit. In addition, the Original Modification Agreement
limits the revolving line note to $2.5 million and the term loan to $6.75
million and established the maturity date for each of these credit lines as
March 31, 2001. Also, the Original Modification Agreement established the
following interest rates for both the revolving line note and term loan: (i)
from March 31, 2000 through August 31, 2000 - prime rate plus 1.0%; (ii) from
September 1, 2000 through October 31, 2000 - prime rate plus 2.0%; and (iii)
from November 1, 2000 through March 31, 2001 - prime rate plus 3.0%. The
scheduled monthly principal payments for the term loan were adjusted to
$83,333.33 from April 2000 through July 2000, $100,000.00 from August 2000
through December 2000 and $125,000.00 from January 2001 through March 2001. As
part of the Original Modification Agreement, the Company issued to Fleet
warrants to purchase 50,000 shares of the common stock at an exercise price of
$0.51 which was equal to the closing price of the common stock for the last five
trading days in the month of August 2000 and warrants to purchase 50,000 shares
of the Company's common stock at an exercise price of $0.156 which was equal to
the closing price of the common stock for the last five trading days in the
month of December of 2000. In August 2000, as a result of a bank merger,
Sovereign Bank of New England ("Sovereign") became the successor party to Fleet
in the Original Modification Agreement.
In November of 2000, the Company and Sovereign entered into the Second
Modification Agreement that amended the Original Modification Agreement in order
to, among other things, defer certain payments required under the term note and
amend certain terms and conditions of the 1999 Agreement. Sovereign deferred the
required principal payments due on December 1, 2000 in the amount of $100,000
and on January 1, 2001 in the amount of $125,000 until March 1, 2001 and March
22, 2001, respectively.
As of December 30, 2000, $5.85 million was borrowed on the term loan and
$2.5 million was borrowed on the revolving credit facility. At December 30,
2000, the Company was in default for non-compliance with certain negative
covenants contained in the Second Modification Agreement relating to minimum net
worth, minimum debt service coverage, maximum funded debt service coverage and
minimum net profit. On March 26, 2001, the Company and its primary lender agreed
to enter into the Third Modification Agreement, which includes a waiver of
defaults relating to these covenants and to a revised credit agreement with
Sovereign. On March 26, 2001, the Company and Sovereign entered into the Third
Modification Agreement. On May 14, 2001, the Company entered into the Amended
and Restated Third Modification Agreement which extended the date for a required
equity infusion to July 2001. The Amended and Restated Third Modification
Agreement includes provisions and financial covenants which supercede the
provisions in the 1999 Agreement and the Original and Second Modification
Agreements, including the following:
a) The maturity dates on each of the revolving line note and the term
loan note are extended to December 31, 2002.
b) Interest rates on the revolving note and term loan are as follows:
February 1, 2001 through September 30, 2001 6%
October 1, 2001 through December 31, 2001 7%
January 1, 2002 through December 31, 2002 Prime rate with
minimum of 8%
and maximum of 11%
44
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(Continued)
c) Scheduled monthly principal payments are as follows:
January 1, 2001 to June 30, 2001 $0
July 1, 2001 to December 31, 2001 $30,000
January 1, 2002 to December 31, 2002 $100,000
d) Failure to complete an equity financing in the amount of $1,000,000
by July 2001 shall constitute an event of default. An equity
financing of $1,750,000 was completed on July 20, 2001 concurrent
with the merger with Eyeshop.
Aggregate maturities of long-term debt, at December 29, 2001 are as follows:
2002......................... $5,979
2003......................... 355
2004......................... 374
2005......................... 23
2006......................... 23
Thereafter................... 153
------
$6,907
======
(7) Lease Obligations
The Company has operating leases primarily for its primary eye care
centers, distribution center, corporate offices and certain equipment. The
leases are generally for periods of up to 10 years with renewal options at fixed
rentals. Certain of the leases provide for additional rentals based on sales
exceeding specified amounts. Capitalized leases consists of various office and
optometric equipment at multiple locations.
45
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(Continued)
Future minimum annual lease commitments for facilities and equipment as of
December 29, 2001 are as follows:
Capital Operating
Leases Leases
------ ------
(In thousands)
2002..................................................... 11 $ 5,694
2003..................................................... 11 4,696
2004..................................................... 8 3,593
2005..................................................... -- 2,831
2006..................................................... -- 2,144
Thereafter............................................... -- 2,400
--- -------
Total minimum lease obligations.......................... 30 $21,358
=======
Less amount representing interest........................ 3
---
Present value of net minimum capital lease obligations... 27
Less current maturities.................................. 10
---
$17
===
Rental expenses charged to operations, including real estate taxes, common
area maintenance and other expenses related to the leased facilities and
equipment, were $6,159,000, $6,409,000 and $6,296,000 for fiscal years 2001,
2000 and 1999 respectively.
(8) Accrued Expenses
Accrued expenses consists of the following:
Years Ended
December
(in thousands)
2001 2000
------ ------
Payroll and related costs ......... $1,187 $1,066
Other ............................. 626 941
------ ------
$1,813 $2,007
====== ======
(9) Redeemable Convertible Preferred Stock
On November 25, 1997, the Company issued 1,452,119 shares of Series B
Convertible Preferred Stock (the "Series B"), Class I and Class II Warrants to
an outside investor (the "Purchaser") for a net purchase price of $4,582,000.
The Series B was purchased with a conversion price into common stock that was
lower than the market value of the common stock, and as a result, the difference
of $1,953,000
46
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(Continued)
was reflected as a dividend to the preferred stockholders to reflect the
preferred stock at its fair value. Each share of Series B is convertible into
one share of Common Stock at $3.50 per share, subject to adjustment, at the
Purchaser's option at any time and at the Company's option if the price per
share of common stock during any period of thirty consecutive trading days
equals or exceeds $7.00 at any time during the first three years or $9.00 at any
time thereafter. The holders of the Series B have the right to appoint one
director to the Company's Board of Directors.
The Class I (Mirror) Warrants entitle the Purchaser to purchase an amount
of shares of the Company's common stock equal to an aggregate of up to 19.9% of
the shares of common stock purchasable under the Company's warrants and options
outstanding as of October 9, 1997 on the same terms and conditions of such
warrant and option holders. The Purchaser is obligated to exercise these
warrants at the same time such options and warrants of existing holders are
exercised, subject to certain limitations.
The Class II Warrants entitle the Purchaser to purchase an aggregate of
657,749 shares of the Company's common stock at an exercise price of $3.09 per
share for a term that expires in November 2002. The number of warrants increased
concurrent with the Eyeshop merger due to anti-dilutive provisions. The increase
in warrants had minimal value.
The Purchaser is entitled to "shelf" registration rights and "piggyback"
registration rights with respect to the shares of common stock underlying the
Series B, the Class I Warrants and the Class II Warrants.
Upon a change of control of the Company, defined as (i) a change in any
person or group obtaining a majority of the securities ordinarily having the
right to vote in an election of Directors; (ii) during any two year period, the
individuals who at the beginning of the period constituted the Company's Board
of Directors no longer constitute a majority of the Board of Directors; (iii)
any merger, consolidation, recapitalization, reorganization, dissolution or
liquidation of the Company which results in the current stockholders no longer
owning more than 50% of the voting securities or the Company; (iv) any sale,
lease, exchange or other transfer of all, or substantially all, of the assets of
the Company; or (v) the adoption of a plan leading to the liquidation or
dissolution of the Company, at the option of the Purchaser, the Company would
have to redeem the Series B at a price of 105% of the offering price, subject to
certain adjustments, plus accrued and unpaid dividends. The redemption value at
December 29, 2001 and December 30, 2000 was $5,337,000.
During 2001, the Redeemable Convertible Preferred Stockholders received
dividends of 1,221,999 shares of common stock.
On July 20, 2001, concurrent with the Eyeshop merger, the preferred
stockholders were granted 1,000,000 warrants at an exercise price of $0.20 per
share for 7.5 years and waived certain rights including potential rights to
anti-dilution adjustments to the preferred stockholders' securities and
redemption rights in connection with a change of control, but solely in
connection with the Eyeshop merger. The estimated fair value of the warrants
were $240,000 and has been allocated to "dividend to preferred shareholders"
during the year ended December 29, 2001.
(10) Stockholders' Equity
Preferred Stock
As of December 29, 2001 and December 30, 2000, the Company has authorized
5,000,000 shares of preferred stock at $.01 par value of which 1,452,119 shares
of Series B are issued and outstanding (see
47
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(Continued)
Note 9), and 200,000 shares have been designated Series A Junior Participating
Preferred Stock pursuant to a certificate of designation filed with the State of
Delaware on May 12, 1997, of which no shares are issued and outstanding. The
terms and conditions of any other series of preferred stock, including any
preferences and dividends, will not be established until such time, if ever, as
such shares are in fact issued by the Company.
Common Stock
As of December 29, 2001 and December 30, 2000, the Company has authorized
50,000,000 and 20,000,000 shares of common stock at $.01 par value,
respectively. Common stock is entitled to dividends if declared by the Board of
Directors, subject to debt agreement restrictions, and each share carries one
vote.
Warrants
In connection with the Company's third public offering in 1996, the
Company sold to its underwriter warrants to purchase an aggregate of 170,000
shares of the Company's common stock at $8.45 per share. The underwriter
warrants expired unexercised on June 25, 2001.
In connection with the Company issuing 1,452,119 shares of Series B
Convertible Preferred Stock, Class I and Class II Warrants were issued to an
outside investor (the "Purchaser"). The Class I (Mirror) Warrants entitle the
Purchaser to purchase an amount of shares of the Company's common stock equal to
an aggregate of up to 19.9% of the shares of common stock purchasable under the
Company's outstanding warrants and options on the same terms and conditions of
existing warrant and option holders. The Purchaser is obligated to exercise
these warrants at the same time the options and warrants of existing holders are
exercised, subject to certain limitations. The Class II Warrants entitle the
Purchaser to purchase an aggregate of 657,749 shares of the Company's Common
Stock at an exercise price of $3.09 per share for a term that expires in
November 2002. No Class I or Class II Warrants have been exercised.
On July 20, 2001, concurrent with the Eyeshop merger, the preferred
shareholders were granted 1,000,000 warrants at an exercise price of $0.20 per
share for 7.5 years and waived certain rights including potential rights to
anti-dulution adjustments to the preferred stockholders' securities and
redemption rights in connection with a change of control, but soleley in
connection with the Eyeshop merger. The estimated fair value of the warrants
were $240,000 and has been allocated to "dividend to preferred shareholders"
during the year ended December 29, 2001.
Treasury Stock
From time to time, the Company's Board of Directors has authorized the
repurchase of shares of the Company's common stock in the open market, subject
to restrictions on debt agreements. There were no repurchases of shares of
common stock during the years ended December 29, 2001, December 30, 2000 and
December 25, 1999.
Stock Option Plan
On November 30, 1992, the Company's Board of Directors and the
stockholders approved the Company's 1992 Employee, Director and Consultant Stock
Option Plan (the "Plan"). On April 26, 1994, the Board of Directors and the
stockholders approved an increase in shares of common stock reserved for
issuance under the Plan to an aggregate of 1,000,000 shares. In March, 1996, the
Board recommended and the stockholders subsequently approved, that an additional
500,000 shares of common stock be
48
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(Continued)
reserved for issuance under the Plan. In December, 1998, the Board recommended,
and the stockholders subsequently approved, that an additional 350,000 shares of
common stock be reserved for issuance under the Plan.
In July 2001, the shareholders approved two amendments to the Plan to
increase the maximum number of shares of Common Stock from 1,850,000 shares to
6,500,000 shares for which stock options may be granted under the Plan and
increase the maximum number of shares of Common Stock from 400,000 shares to
2,250,000 shares for which options may be granted to any participant under the
Plan in any consecutive three year period.
Under the Plan, incentive stock options may be granted to employees of the
Company. Non-qualified stock options may be granted to consultants, directors,
employees or officers of the Company. Most options vest after two or three years
from date of grant with a maximum term of ten years.
Concurrent with the Eyeshop merger, the Company assumed the Eyeshop option
plan and certain Eyeshop options were converted to options in the Company with a
weighted average exercise price of 20 cents. The total options outstanding under
this plan are 1,757,096 with half vesting on March 30, 2002 and half vesting on
March 30, 2003. There are no more additional options available under the Eyeshop
plan.
The Company applies APB Opinion No. 25 and related interpretations in
accounting for the Plan and as a result no compensation expense has been
recorded for granted options. Had compensation costs been determined consistent
with FASB Statement No. 123, the Company's net loss and loss per share would
have been as follows:
2001 2000 1999
---- ---- ----
(in thousands except for per share data)
Net loss.............. as reported $ (5,487) $ (5,004) $ (2,854)
======== ======== ========
pro forma $ (5,679) $ (5,019) $ (3,370)
======== ======== ========
Net loss per share.... as reported $ (0.34) $ (0.55) $ (0.30)
======== ======== ========
pro forma $ (0.35) $ (0.55) $ (0.36)
======== ======== ========
The fair value of each option grant is estimated on the date of grant using the
Black-Scholes option pricing model with the following weighted average
assumptions used for grants as follows:
2001 2000 1999
---- ---- ----
Dividend Yield................... 0.00% 0.00% 0.00%
Volatility....................... 112.0% 115.7% 90.4%
Interest Rate.................... 5.0% 4.88% 6.60%
Expected Life.................... 7.00 years 5.03 years 6.49 years
49
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(Continued)
A summary of the stock option transactions are as follows:
Number of Weighted
Shares Average
Under Price per
Option Share
------ -----
Balance, December 25, 1998 1,203,729 $4.16
Increase to the plan -- --
Canceled (97,667) 5.04
Granted 289,000 2.25
Exercised (5,000) 0.43
---------- -----
Balance, December 25, 1999 1,390,062 3.71
Canceled (346,464) 3.76
Granted 20,000 0.91
Exercised (5,000) 0.43
---------- -----
Balance, December 30, 2000 1,058,598 3.66
Canceled (730,098) 3.71
Granted 4,121,000 0.36
Assumed from Eyeshop 1,757,096 0.20
Exercised -- --
---------- -----
Balance, December 29, 2001 6,206,596 $0.50
========== =====
As of December 29, 2001, there were 2,050,500 additional options available for
grant.
50
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(Continued)
There were 401,418 and 841,281 shares exercisable under the Plans at
December 29, 2001 and December 30, 2000, respectively.
The weighted average fair value of options granted under the Plans was
$0.29 and $0.75 for the years ended December 31, 2001 and December 30, 2000,
respectively.
The following table summarizes information about options outstanding under
the Plans as of December 29, 2001:
Options Outstanding Options Exercisable
------------------- -------------------
Weighted
average Weighted
Range of Number remaining average Number Weighted
Exercise outstanding contractual exercise exercisable at Average
Prices at 12/29/2001 life price 12/29/2001 Exercise price
------ ------------- ---- ----- ---------- --------------
$0.00-$0.49 5,783,096 9.49 $ 0.31 25,500 $ 0.36
$0.50-$0.99 115,000 4.23 $ 0.55 105,001 $ 0.52
$1.00-$1.99 0 0 $ 0 0 $ 0
$2.00-$2.99 99,500 7.69 $ 2.03 70,919 $ 2.02
$3.00-$3.99 27,000 7.48 $ 3.35 21,665 $ 3.57
$4.00-$4.99 81,700 6.19 $ 4.36 80,033 $ 4.36
$5.00-$6.88 100,300 4.13 $ 5.98 98,300 $ 5.98
--------- -------
6,206,596 401,418
========= =======
(11) Non-recurring Severance and Consolidation Expenses
During 2001 the Company incurred non-recurring severance and consolidation
expenses of $773,000 for the closing and consolidating of laboratory and
distribution centers and closing and relocating the Company's headquarters from
Holliston, Massachusetts to Cincinnati, Ohio. During these closures, the Company
severed about 50 people and incurred severance costs and consulting costs with
former employees of approximately $500,000. Further, the Company incurred costs
to "buy out" the lease on the former headquarters of $135,000 (see Note 17). The
Company abandoned approximately $40,000 of assets at these facilities and
incurred moving and travel expenses of $98,000. Non-recurring severance and
consolidation expenses that were unpaid and accrued at December 29, 2001 were
$295,000.
51
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(Continued)
(12) Employee Benefit Plans
The Company maintains a 401(k) Retirement Savings Plan. The Company
matches 50% of every dollar contributed by employees, limited to the first 5% of
salary. Contributions made by the Company in 2001, 2000 and 1999 were $263,000,
$231,000 and $247,000, respectively.
(13) Income Taxes
Income tax benefit attributable to loss from operations differed from the
amounts computed by applying the U.S. federal income tax rate of 34 percent as a
result of the following:
Years Ended December
--------------------
2001 2000 1999
------- ------- -------
(in thousands)
Computed "expected" tax benefit ....................... $ 1,866 $ 1,674 $ 954
Increase in tax benefit resulting from:
State net operating loss and State tax deductions .. 190 213 142
Decrease in tax benefit resulting from:
Other .............................................. (73) (203) (158)
Increase in valuation allowance for deferred tax
assets allocated to income tax expense .......... (2,069) (1,764) (1,015)
------- ------- -------
$ (86) $ (80) $ (77)
======= ======= =======
52
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(Continued)
The tax effects of temporary differences that give rise to significant
portions of the net deferred tax asset are presented below:
Years Ended December
--------------------
2001 2000
---- ----
(in thousands)
Deferred tax assets:
Net operating loss carryforwards ............ $ 10,749 $ 9,576
Plant and equipment ......................... 902 639
Vacation accrual ............................ 206 41
Bad debt reserve ............................ 722 687
Other reserves .............................. 442 237
-------- --------
Gross deferred tax assets .............. 13,021 11,180
Valuation allowance under SFAS 109 .......... (11,197) (8,879)
-------- --------
Deferred tax assets .................. 1,824 2,301
======== ========
Deferred tax liabilities:
Intangible assets ....................... (1,824) (2,301)
-------- --------
Net deferred tax assets ......... $ 0 $ 0
======== ========
A valuation allowance in the amount of $11,197,000 and $8,879,000 was
established at December 29, 2001 and December 30, 2000, respectively. This
allowance has been established due to the uncertainty of the Company to benefit
from the deferred tax assets.
Subsequently recognized tax benefit relating to the valuation allowance
for deferred tax assets will be allocated as follows:
Years Ended December
--------------------
2001 2000
------- ------
(in thousands)
Income tax benefit that would be reported
in the statement of operations ................... $10,726 $8,408
Charge to goodwill for recognition of
acquired tax assets .............................. 471 471
------- ------
$11,197 $8,879
======= ======
The net operating loss carryforwards for federal and state tax purposes at
December 29, 2001 are approximately $28,074,000 and $15,053,000, respectively
and expire through 2021 and 2006, respectively.
53
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(Continued)
(14) Supplementary Cash Flow Information
The following represents supplementary cash flow information:
Years Ended December
--------------------
2001 2000 1999
-------- -------- --------
(in thousands)
Interest paid ............................... $ 768 $ 952 $ 538
Income taxes paid ........................... 49 72 98
Non-cash financing activities:
Acquisitions:
Assets acquired ............................. 2,349 -- 12,632
Net liabilities assumed ..................... (310) -- (4,371)
Notes payable ............................... -- -- (1,300)
Common stock issued ......................... (2,054) -- (2)
-------- -------- --------
Cash paid ................................... (15) -- 6,959
Less cash acquired .......................... 15 -- (540)
-------- -------- --------
Net cash paid for acquisition ............... $ -- $ -- $ 6,419
======== ======== ========
(15) Related Party Transactions
In connection with the exercise of stock options to purchase 138,332
shares (the "Option Shares") of the Company's common stock during fiscal 1997,
Stephen M. Blinn, a former executive officer and current Director of the
Company, executed a promissory note (the "Note") in favor of the Company for the
aggregate exercise price of $594,111. The Note is due on the earlier of
September 2, 2007 or the date upon which Mr. Blinn receives the proceeds of the
sale of not less than 20,000 of the Option Shares (the "Maturity Date").
Interest accrues at the rate of 6.55% , compounding annually, and is payable on
the earlier of the Maturity Date of the Note or upon certain Events of Default
as defined in the Note. The principal balance of the Note, together with the
accrued and unpaid interest, was approximately $714,000 as of December 29, 2001.
During the third quarter of fiscal 2000, Mr. Blinn has informed the Company that
he understood that the terms of the Note permitted Mr. Blinn to satisfy in full
his obligations under the Note by either (a) returning the Option Shares to the
Company or (b) turning over to the Company any cash proceeds received by Mr.
Blinn upon a sale of the Option Shares. The Company has informed Mr. Blinn that
the Note is a full recourse promissory note, and that Mr. Blinn remains
personally liable for all unpaid principal and interest under the Note. Due to
Mr. Blinn's position regarding the Note and his failure to provide the Company
or the Company's accountants with a copy of his personal financial statements or
any other evidence of his ability to pay the amounts due under the Note, the
Company has established a $714,000 reserve in accordance with generally accepted
accounting principles for notes receivable in respect of the Note and subsequent
to the establishment of the reserve, the Company no longer recognizes as
interest income accrued interest related to this note. Despite the reserve, the
Company intends to take all measures necessary to collect the amounts due from
Mr. Blinn.
54
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(Continued)
(16) Supplementary Financial Information
Quarterly Financial Data (Unaudited)
(In thousands, except per share)
2001 First Second Third Fourth Year
---- ----- ------ ----- ------ ----
Net Sales $16,059 $14,505 $15,290 $13,095 $58,949
Gross Profit 11,141 9,683 10,413 9,186 40,423
Income/(Loss) from operations (48) (1,716) (818) (1,998) (4,580)
Net loss (306) (1,952) (994) (2,235) (5,487)
Basic and diluted loss per
common share (0.05) (0.21) (0.05) (0.08) (0.34)
2000 First Second Third Fourth Year
---- ----- ------ ----- ------ ----
Net Sales $17,519 $16,483 $16,885 $13,332 $64,219
Gross Profit 12,117 11,363 11,311 8,499 43,290
Income/(loss) from operations (51) (334) (76) (2,404) (2,865)
Net income (loss) (287) (695) (1,246) (2,776) (5,004)
Basic and diluted earnings
(loss) per common share (0.03) (0.08) (0.14) (0.31) (0.55)
(17) Subsequent Events
In February 2002, the Company entered with a settlement agreement with
John C. Cress, Timothy D. Westra and Kent Acquisition Corp. in which the Company
agreed to issue 1,100,606 of unregistered shares of SRC common stock as
additional consideration in connection with such contingent obligations incurred
in the acquisition. Those shares were issued on February 27, 2002. Additionally,
the payment terms and interest on the outstanding acquisition notes of $667,000
and outstanding obligations from the acquisition contract of $100,000 were
revised (see Note 6).
Further, in February 2002, the Company signed a lease buy-out contract on
its former headquarters in Holliston, Massachusetts, agreeing to pay a total of
$135,000 during 2002. This contract released the Company of its lease
obligations through October, 2004 which aggregated $540,000. Additionally, the
Company abandoned approximately $20,000 of leasehold improvements related to
that facility. These expenses were included in the "Non-recurring severance and
consolidation expenses" in the 2001 results of operations.
In March 2002, the Company and LVCI mutually terminated their agreement
effective February 28, 2002. There was no income or cost to the Company for the
termination.
Item 9. Changes in and Disagreements with Accountants on Accounting and
Financial Disclosure
None.
55
PART III
Item 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT
The response to this item is incorporated by reference from the discussion
responsive thereto under the captions "Management" and "Compliance with Section
16(a) of the Securities Exchange Act of 1934" in the Company's Proxy Statement
for the 2002 Annual Meeting of Stockholders.
Item 11. EXECUTIVE COMPENSATION
The response to this item is incorporated by reference from the discussion
responsive thereto under the caption "Executive Compensation" in the Company's
Proxy Statement for the 2002 Annual Meeting of Stockholders.
Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The response to this item is incorporated by reference from the discussion
responsive thereto under the caption "Share Ownership" in the Company's Proxy
Statement for the 2002 Annual Meeting of Stockholders.
Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
The response to this item is incorporated by reference from the discussion
responsive thereto under the caption "Certain Relationships and Related
Transactions" and "Executive Compensation--Employment Agreements, Termination of
Employment and Change of Control Arrangements" in the Company's Proxy Statement
for the 2002 Annual Meeting of Stockholders.
Item 14. Exhibits, Financial Statement Schedules, and Reports on Form 8-K
Item 14(a)(1). Index to Consolidated Financial Statements Covered by Report of
Independent Auditors
The Consolidated Financial Statements of Sight Resource Corporation are included
in Item 8:
. Independent Auditors' Report
. Consolidated Balance Sheets as of December 29, 2001 and December 30,
2000
. Consolidated Statements of Operations for the Years Ended December 29,
2001, December 30, 2000 and December 25, 1999, respectively
56
. Consolidated Statements of Stockholders' Equity for the Years Ended
December 29, 2001, December 30, 2000 and December 25, 1999,
respectively
. Consolidated Statements of Cash Flows for the Years Ended December 29,
2001, December 30, 2000 and December 25, 1999, respectively
. Notes to Consolidated Financial Statements
Item 14(a)(2). Consolidated Financial Statement Schedules
57
INDEPENDENT AUDITORS' REPORT
The Board of Directors and Stockholders
Sight Resource Corporation:
Under date of March 21, 2002 we reported on the consolidated balance
sheets of Sight Resource Corporation and its subsidiaries as of December 29,
2001 and December 30, 2000, and the related consolidated statements of
operations, stockholders' equity, and cash flows for each of the years in the
three-year period ended December 29, 2001, which are included in the annual
report on Form 10-K for the year 2001. In connection with our audits of the
aforementioned consolidated financial statements, we also audited the related
consolidated financial statement schedule in the annual report on Form 10-K.
This financial statement schedule is the responsibility of the Company's
management. Our responsibility is to express an opinion on this financial
statement schedule based on our audits.
In our opinion, such financial statement schedule, when considered in
relation to the basic consolidated statements taken as a whole, presents fairly,
in all material respects, the information set forth therein.
The audit report on the consolidated financial statements of Sight
Resource Corporation and its subsidiaries referred to above contains an
explanatory paragraph that states that the Company's recurring losses and its
ability to pay its outstanding debt raise substantial doubt about the entity's
ability to continue as a going concern. The financial statement schedule
included in the annual report on Form 10-K does not include any adjustments that
might result from the outcome of this uncertainty.
/s/ KPMG LLP
Boston, Massachusetts
March 21, 2002
58
SIGHT RESOURCE CORPORATION
Schedule II--Valuation and Qualifying Accounts
(dollars in thousands)
FOR THE TWELVE MONTHS ENDED DECEMBER 29, 2001
Additions (Deductions)
----------------------
Charged
Balance at (Credited) to Balance at
Beginning Costs and Other End of
Description of Year Expenses Net Period
----------- ------- -------- --- ------
Valuation and qualifying accounts deducted from assets:
Allowances for accounts receivable .................... $1,897 $ 317 $(299)/(1)/ $ 1,915
Valuation allowance for deferred tax assets ........... 8,879 2,318 -- 11,197
/(1)/ Represents losses charged to reserves
FOR THE TWELVE MONTHS ENDED DECEMBER 30, 2000
Additions (Deductions)
----------------------
Charged
Balance at (Credited) to Balance at
Beginning Costs and Other End of
Description of Year Expenses Net Period
----------- ------- -------- --- ------
Valuation and qualifying accounts deducted from assets:
Allowances for accounts receivable .................... $1,881 $ 588 $(572)/(1)/ $1,897
Valuation allowance for deferred tax assets ........... 7,115 1,764 0 8,879
/(1)/ Represents losses charged to reserves
59
FOR THE TWELVE MONTHS ENDED DECEMBER 25, 1999
Additions (Deductions)
----------------------
Charged
Balance at (Credited) to Balance at
Beginning Costs and Other End of
Description of Year Expenses Net Period
----------- ------- -------- --- ------
Valuation and qualifying accounts deducted from assets:
Allowances for accounts receivable..................... $ 748 $1,233 $ (100)/(1)/ $1,881
Valuation allowance for deferred tax assets............ 8,810 1,015 (2,710)/(2)/ 7,115
/(1)/ Represents losses charged to reserves
/(2)/ The valuation allowance was reduced due to acquisition costs that
resulted in the recognition of deferred tax liabilities.
Item 14(a)(3) Exhibits
The exhibits listed below are filed herewith or incorporated herein by
reference, as indicated below, as part of this report.
Exhibit
Number Description
------ -----------
(2.1) Stock Purchase and Sale Agreement, dated as of April 1, 1999, by and
among Kent Optical Company, Custom Optics, Inc., Kent-N.W. Grand
Rapids, Inc., Kent-Hackley, Inc., Source Optical Supply, Inc., the
stockholders of such companies, Kent Acquisition Corporation and
Sight Resource Corporation (incorporated herein by reference to
Exhibit 2.1 of the Company's Form 8-K filed with the Securities and
Exchange Commission on May 6, 1999)
(3.1) Restated Certificate of Incorporation of the Company, as amended
(incorporated herein by reference to Exhibit 3.1 of the Company's
Form 10-Q filed with the Securities and Exchange Commission on
November 19, 2001)
(3.2) By-Laws of the Company, as amended (incorporated herein by reference
to Exhibit 3.2 of the Company's Registration Statement filed with the
Securities and Exchange Commission on Form SB-2 File No. 33-56668)
(3.3) Certificate of Designation for Series A Junior Participating
Preferred Stock (incorporated herein by reference to Exhibit 1 of the
Company's Form 8-K filed with the Securities and Exchange Commission
on May 13, 1997)
60
(3.4) Certificate of Designation, Preferences and Rights of Series B
Convertible Preferred Stock (incorporated herein by reference to
Exhibit 4.1 of the Company's Form 8-K filed with the Securities and
Exchange Commission on December 9, 1997)
(4.1) Article 4 of the Certificate of Incorporation (incorporated herein by
reference to Exhibit 3.1 of the Company's Registration Statement
filed with the Securities and Exchange Commission on Form SB-2 File
No. 33-56668)
(4.2) Form of Common Stock Certificate (incorporated herein by reference to
Exhibit 4.2 of the Company's Registration Statement filed with the
Securities and Exchange Commission on Form SB-2 File No.
33-56668)
(4.3) Form of Class I (Mirror) Warrants (incorporated herein by reference
to Exhibit 4.2 of the Company's Form 8-K filed with the Securities
and Exchange Commission on December 9, 1997)
(4.4) Form of Class II Warrants (incorporated herein by reference to
Exhibit 4.3 of the Company's Form 8-K filed with the Securities and
Exchange Commission on December 9, 1997)
4.5 Form of Warrant to Purchase Common Stock issued to Carlyle
Venture Partners, L.P., C/S Venture Investors, L.P., Carlyle U.S.
Venture Partners, L.P. and Carlyle Venture Coinvestment, L.L.C.
4.6 Registration Rights Agreement, dated July 20, 2001, between the Sight
Resource Corporation and Carlyle Venture Partners, L.P., C/S Venture
Investors, L.P., Carlyle U.S. Venture Partners, L.P. and Carlyle
Venture Coinvestment, L.L.C.
(10.1) 1992 Employee, Director and Consultant Stock Option Plan, as amended
(incorporated by reference herein to Exhibit 10.1 of the Company's
Form 10-Q filed with the Securities and Exchange Commission on August
14, 2001)
(10.2) Employment Agreement, dated as of January 26, 1998, between Sight
Resource Corporation and William T. Sullivan (incorporated herein by
reference to Exhibit 10.6 of the Company's Form 10-K for the year
ended December 31, 1998 filed with the Securities and Exchange
Commission)
(10.3) Amendment No. 1 to Employment Agreement, dated as of December 4,
1998, between Sight Resource Corporation and William T. Sullivan
(incorporated herein by reference to Exhibit 10.7 of the Company's
Form 10-K for the year ended December 31, 1998 filed with the
Securities and Exchange Commission)
61
(10.4) Letter Agreement, dated as of July 27, 1998, between Sight Resource
Corporation and William G. McLendon (incorporated herein by reference
to Exhibit 10b of the Company's Form 8-K filed with the Securities
and Exchange Commission on November 13, 1998)
(10.5) Letter Agreement, dated as of August 3, 1998, between Sight Resource
Corporation and Stephen M. Blinn (incorporated herein by reference to
Exhibit 10c of the Company's Form 8-K filed with the Securities and
Exchange Commission on November 13, 1998)
(10.6) Employment Agreement, dated as of August 17, 1998, between Sight
Resource Corporation and James W. Norton (incorporated herein by
reference to Exhibit 10a of the Company's Form 8-K filed with the
Securities and Exchange Commission on November 13, 1998)
(10.7) Form of Management Agreement between certain of the Company's
subsidiaries and their related optometric professional corporations
(incorporated herein by reference to Exhibit 10.11 of the Company's
Form 10-K for the year ended December 31, 1998 filed with the
Securities and Exchange Commission)
(10.8) Form of Stock Restrictions and Pledge Agreement between certain of
the Company's subsidiaries, their related optometric professional
corporations and the nominee shareholders (incorporated herein by
reference to Exhibit 10.12 of the Company's Form 10-K for the year
ended December 31, 1998 filed with the Securities and Exchange
Commission)
(10.9) Asset Purchase Agreement, dated February 24, 1995 between Sight
Resource Corporation, CEA Acquisition Corporation, Cambridge Eye
Associates, Inc. and Elliot S. Weinstock, O.D. (incorporated herein
by reference to Exhibit 2.1 of the Company's Form 8-K filed with the
Securities and Exchange Commission on March 8, 1995)
(10.10) Credit Agreement, dated February 20, 1997, between Sight Resource
Corporation and Creditanstalt Corporate Finance Corporation, Inc.
(incorporated herein by reference to Exhibit 10.1 of the Company's
Form 8-K filed with the Securities and Exchange Commission on March
7, 1997)
(10.11) Asset Purchase Agreement, dated August 24, 1995, between Sight
Resource Corporation, Douglas Vision World, Inc., S.J. Haronian,
Kathleen Haronian, Lynn Haronian, Shirley Santoro and Tri-State
Leasing Company (incorporated herein by reference to Exhibit 2.1 of
the Company's Form 8-K filed with the Securities and Exchange
Commission on September 8, 1995)
(10.12) Asset Transfer and Merger Agreement, dated as of July 1, 1996, by and
among Sight Resource Corporation, E.B. Acquisition Corp., The E.B.
Brown Optical Company, Brown Optical Laboratories, Inc., E.B. Brown
Opticians, Inc., Gordon Safran and Evelyn Safran (incorporated herein
by reference to Exhibit 2.1 of the Company's Form 8-K filed with the
Securities and Exchange Commission on October 3, 1996.)
62
(10.13) Form of Rights Agreement, dated as of May 15, 1997, between Sight
Resource Corporation and American Stock Transfer & Trust Company
(incorporated herein by reference to Exhibit 1 of the Company's Form
8-K filed with the Securities and Exchange Commission on May 13,
1997)
10.14 Amendment to Rights Agreement, dated May 17, 2001, between Sight
Resource Corporation and American Stock Transfer & Trust Company
(10.15) Stock Purchase Agreement, dated as of July 1, 1997, by and among
Marjory O. Greenberg, As Testamentary Executrix of the Succession of
Tom I. Greenberg, Peter Brown, and Vision Plaza Corp. (incorporated
herein by reference to Exhibit 10.1 of the Company's Form 10-Q filed
with the Securities and Exchange Commission on November 12, 1997)
(10.16) Promissory Note, dated as of September 2, 1997, between Sight
Resource Corporation and Mr. Stephen Blinn (incorporated herein by
reference to Exhibit 10.2 of the Company's Form 10-Q filed with the
Securities and Exchange Commission on November 12, 1997)
(10.17) Series B Convertible Preferred Stock Agreement (incorporated herein
by reference to Exhibit 10.1 of the Company's Form 8-K filed with the
Securities and Exchange Commission on December 9, 1997)
(10.18) Loan Agreement, dated as of April 1, 1999, by and between Sight
Resource Corporation and Fleet National Bank (incorporated herein by
reference to Exhibit 99.1 of the Company's Form 8-K filed with
Securities and Exchange Commission on May 6, 1999)
(10.19) $7,000,000 Term Loan Note, dated as of April 1, 1999, between Sight
Resource Corporation and Fleet National Bank (incorporated herein by
reference to Exhibit 99.2 of the Company's Form 8-K filed with
Securities and Exchange Commission on May 6, 1999)
(10.20) $3,000,000 Secured Revolving Line Note, dated as of April 1, 1999,
between Sight Resource Corporation and Fleet National Bank
(incorporated herein by reference to Exhibit 99.3 of the Company's
Form 8-K filed with Securities and Exchange Commission on May 6,
1999)
(10.21) $10,000,000 Secured Acquisition Term Note, dated as of April 1, 1999,
between Sight Resource Corporation and Fleet National Bank
(incorporated herein by reference to Exhibit 99.4 of the Company's
Form 8-K filed with Securities and Exchange Commission on May 6,
1999)
63
(10.22) Borrower Security Agreement, dated as of April 1, 1999, by and
between Sight Resource Corporation and Fleet National Bank
(incorporated herein by reference to Exhibit 99.5 of the Company's
Form 8-K filed with Securities and Exchange Commission on May 6,
1999)
(10.23) Borrower Stock Pledge Agreement, dated as of April 1, 1999, by and
between Sight Resource Corporation and Fleet National Bank
(incorporated herein by reference to Exhibit 99.6 of the Company's
Form 8-K filed with Securities and Exchange Commission on May 6,
1999)
(10.24) Trademark Security Agreement, dated as of April 1, 1999, by and
between Sight Resource Corporation and Fleet National Bank
(incorporated herein by reference to Exhibit 99.7 of the Company's
Form 8-K filed with Securities and Exchange Commission on May 6,
1999)
(10.25) Modification Agreement, dated March 31, 2000, between Sight Resource
Corporation and Fleet National Bank (incorporated by reference herein
to Exhibit 10.1 of the Company's Form 10-Q filed with the Securities
and Exchange Commission on May 9, 2000)
(10.26) Second Modification Agreement, dated November 30, 2000, between Sight
Resource Corporation and Sovereign Bank of New England (incorporated
by reference herein to Exhibit 99.1 of the Company's Form 8-K filed
with the Securities and Exchange Commission on December 15, 2000)
(10.27) Third Modification Agreement, dated March 26, 2001, between Sight
Resource Corporation and Sovereign Bank (incorporated by reference to
Exhibit E of Annex B to the Company's Definitive Proxy Statement
filed with the Securities and Exchange Commission on June 21, 2001)
(10.28) Amended and Restated Third Modification Agreement, dated May 14,
2001, between Sight Resource Corporation and Sovereign Bank
(incorporation herein by reference to Exhibit 10.1 to the Company's
Form 10-Q filed with the Securities and Exchange Commission on August
14, 2001)
(10.29) Settlement Agreement and Mutual Release, dated March 20, 2001, by and
among Sight Resource Corporation, Shawnee Optical, Inc. and each of
Robert U. Leonardi, Judith R. Servis and Christopher J. Wolf, O.D.
(incorporated by reference to Exhibit 10.1 of the Company's Form 10-Q
filed with the Securities and Exchange Commission on May 15, 2001)
64
(10.30) Letter Agreement, dated May 21, 2001, between Sight Resource
Corporation and Carlyle Venture Partners, L.P. (incorporated by
reference to Exhibit F to Annex B of the Company's Definitive Proxy
Statement filed with the Securities and Exchange Commission on June
21, 2001)
(10.31) Common Stock Purchase Agreement, dated May 23, 2001, by and among
Sight Corporation, eyeshop.com, inc. and the listed on Exhibit A
attached thereto (incorporated by reference to Exhibit 99.1 of the
Company's Form 8-K filed with the Securities and Exchange Commission
on May 25, 2001)
(10.32) Agreement and Plan of Merger, dated as of May 23, 2001, by and among
Sight Corporation, Eyeshop Acquisition Corp. and eyeshop.com, inc.
(incorporated by reference to Exhibit 99.2 of the Company's Form 8-K
filed with the Securities and Exchange Commission on May 25, 2001)
(10.33) Common Stock Purchase Agreement, dated May 31, 2001, by and among
Sight Resource Corporation and the purchasers listed on Exhibit A
attached thereto (incorporated by reference to Exhibit 99.1 of the
Company's Form 8-K filed with the Securities and Exchange Commission
on June 8, 2001)
10.34 Separation Letter Agreement, dated May 23, 2001, between Sight
Resource Corporation and William Sullivan
10.35 Separation Letter Agreement, dated October 12, 2001, between Sight
Resource Corporation and James Norton
(10.36) Lease Agreement, dated July 9, 2001, between Sight Resource
Corporation and Park Place, LLC (incorporated by reference herein to
Exhibit 10.1 of the Company's Form 10-Q filed with the Securities and
Exchange Commission on November 19, 2001)
21 Subsidiaries of the Company
(99.1) Audit Committee Charter of the Company (incorporated by reference to
Annex E of the Company's Definitive Proxy Statement filed with the
Securities and Exchange Commission on June 21, 2001)
----------
Management contract or compensatory plan, contract or arrangement.
Item 14(b) Reports on Form 8-K
The Company filed no reports on Form 8-K during the quarter ended December
29, 2001.
65
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized, in Cincinnati, Ohio on
March 29, 2002.
SIGHT RESOURCE CORPORATION
/s/ CARENE KUNKLER
By:
Carene Kunkler
President and Chief Executive Officer
Pursuant to the requirements of the Securities Exchange Act of 1934, this
report has been signed below by the following persons on behalf of the
Registrant and in the capacities on the dates indicated.
Signature Title Date
--------- ----- ----
President (principal
/s/ CARENE S. KUNKLER executive officer), March 29, 2002
---------------------------- Chief Executive Officer
Carene S. Kunkler and Director
/s/ E. DEAN BUTLER Chairman March 29, 2002
----------------------------
E. Dean Butler
/s/ CHRISTIAN E. CALLSEN Director March 29, 2002
----------------------------
Christian E. Callsen
/s/ WILLIAM B. CONNELL Director March 29, 2002
----------------------------
William B. Connell
66
/s/ RYAN SCHWARZ Director March 29, 2002
----------------------------
Ryan Schwarz
/s/ WILLIAM G. MCLENDON Director March 29, 2002
----------------------------
William G. McLendon
/s/ DINO TABACCHI Director March 29, 2002
----------------------------
Dino Tabacchi
/s/ RUSSELL E. TASKEY Director March 29, 2002
----------------------------
Russell E. Taskey
/s/ DUANE KIMBLE Chief Financial Officer March 29, 2002
---------------------------- (principal financial and
Duane Kimble accounting officer)
67
Exhibit Index
-------------
Exhibit
Number Description
------ -----------
4.5 Form of Warrant to Purchase Common Stock issued to Carlyle Venture
Partners, L.P., C/S Venture Investors, L.P., Carlyle U.S. Venture
Partners, L.P. and Carlyle Venture Coinvestment, L.L.C.
4.6 Registration Rights Agreement, dated July 20, 2001, between the Sight
Resource Corporation and Carlyle Venture Partners, L.P., C/S Venture
Investors, L.P., Carlyle U.S. Venture Partners, L.P. and Carlyle
Venture Coinvestment, L.L.C.
10.14 Amendment to Rights Agreement, dated May 17, 2001, between Sight
Resource Corporation and American Stock Transfer & Trust Company
10.34 Separation Letter Agreement, dated May 23, 2001, between Sight Resource
Corporation and William Sullivan
10.35 Separation Agreement, dated October 12, 2001, between Sight Resource
Corporation and James Norton
21 Subsidiaries of the Company